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Plasma total alkaline phosphatases (ALPs) has long been 
recognized as a marker of osteoblastic activity. However, the lack of 
tissue specificity renders it an insensitive index in monitoring the 
progress of disease and response to treatment. With the selective 
precipitation method by wheat germ lectin (Rosalki and Foo, 1986) 
bone-specific ALP could be quantitatively separated from the other 
isoenzymes in plasma samples. With this method, we found that the 
normal plasma level of bone-specific ALP of the local male adults was 
39.76 16.68 U/L whereas that of the females was 31.36 12.41 U/L. 
In the patients with long bone fracture, the plasma level of bone-specific 
ALP significantly increased between week 5 to week 15 after fracture 
and returned to normal after week 24. Patients with osteosarcoma 
demonstrated a significant increase in the plasma level of bone-specific 
ALP. 
The plasma level of bone-specific ALP was also determined in 
experimentally-produced fracture in rabbit tibia. The levels were used to 
monitor the progress of fracture healing. Results demonstrated that there 
was an initial drop of the plasma bone-specific ALP one week after 
fracture. The levels then gradually increased reaching a peak value at 
week 7. Subsequently, the levels declined to the low level. Radiological 
findings showed that union occurred between week 6 and week 8. It is 
reasonable to conclude that union had occurred after the plasma level of 
bone-specific ALP started to decline. Bone-specific ALP activities in 
callus formed at the fracture site was found to be very high in the early 
bony callus stage which composed mainly of woven bone. Low levels 
x 
Abstract 
were found in the late bony callus stage or stage of remodeling after the 
woven bones had been replaced by lamellar bone. 
In vitro culture of normal fetal rat calvarial osteoblasts and rat 
UMR-106 osteosarcoma demonstrated the direct relationship of the level 
of cellular bone-specific ALP and the osteogenic capacity. Higher bone-
specific ALP content always corresponded to the higher amount of 
calcium phosphatase deposits and the higher rate of collagen synthesis. 
Higher bone-specific ALP levels found in serum of osteosarcoma-
bearing patients might be due to the higher release of bone-specific ALP 
from these malignant cells as proven by the finding that higher amount 
of bone-specific ALP was released into the medium by the in vitro 






Introduction Alkaline Phosphatase 
The importance of the measurement of serum alkaline 
phosphatase activity has not decreased during the elapsed half century 
since its introduction into diagnostic enzymology. Indeed, its position 
amongst the most frequently performed tests in clinical chemistry has 
been consolidated by the growth of multiparameter biochemical 
profiling. Alkaline phosphatase determinations were first applied to the 
investigation of bone diseases through their demonstration of the 
association between an increased serum alkaline phosphatase activity 
and increased osteoblastic activity in bone. 
1.1 INTRODUCTION TO ALKALINE PHOSPHATASE 
1.1.1 The Alkaline Phosphatase Isoenzymes 
The human alkaline phosphatase [orthophosphoric-monoester 
phosphohydrolase (alkaline optimum), E.C.3.1.3.1, ALP] comprise a 
spectrum of multiple molecular forms originating from various organs 
including liver, bone, kidney, small intestine and placenta during 
pregnancy. These various forms of ALP catalyze the hydrolysis of 
organic phosphate esters optimally at alkaline conditions (pH ~ 9 to 10) 
liberating the inorganic phosphate group and an alcohol (Fig. 1-1). 
Therefore, they constitute a system of isoenzymes (isozymes). 
\ , 
The ALP isoenzymes differ from one another partly by genetic 
factors and by post-translational modifications. The placental, intestinal 
and the so-called tissue non-specific alkaline phosphatases (TNS-ALPs) • . . 
(Griffiths and Black, 1987) differ by their primary sequences of the 
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O O || ALP II 
S—O— P— O- + OH" s — O H + "O—-P-0-
. Alkaline
 0 • 
Substrates Product Inorganic 
Phosphate 
Fig. 1-1 General reaction that alkaline phosphatases catalyse. 
polypeptide chain and therefore, they are the products from different 
genetic loci. They are also antigenically different. The TNS-ALPs, 
including the skeletal, hepatic and renal enzymes, are generally accepted 
as the products of a single genetic locus; hence, they are not true 
isoenzymes. They differ in the degree of post-translational modification 
glycosylation (Fig. 1-2). Strictly speaking, they can only be 
referred as isoforms. 
Gpnfi i fivel EostlcansIfllIflnflLJVlQditotl0a 
(laoaozymfis) (lsolorms). 
r Placental r Skeletal 
ALPs Tissue Non-specific Hepatic 
- In tes t ina l L R e n a l 
Fig. 1-2 Alkaline phosphatase isoenzymes 
Previous reports showed that the carbohydrates moiety of the 
ALP glycoproteins contains hexosamine (e.g., N-acetylglucosamine), 
hexose (e.g., mannose, glucose, fucose) and sialic acid (N_ 
acetylneuraminic acid) (Ghosh and Fishman, 1968; Hiwada and 
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Wachsmuth, 1974; Fosset et al, 1974). Other reports also demonstrated 
that the carbohydrate side chains protect the enzyme against protease 
digestion (Komoda and Sakagishi, 1976a). The carbohydrates moiety 
also acts as a negative cooperative factor to enzyme activity (Komoda 
and Sakagishi, 1976b) and serves as a specific binding site in the 
interaction of the enzyme with concanavalin A (Komoda and Sakagishi, 
1976a). 
Komoda and Sakagishi (1978) demonstrated that the sialic 
acid residues may also stabilize the native conformation of the active 
enzymes when subjected to heating and to pronase digestion. The 
evidences were supported by their observations of a decrease in the helix 
contents from 39.0% to 30.8% and the half-life dropped to about 20% 
when the hepatic enzymes were desialated. Yet conformational changes 
have already been demonstrated in human prostate acid phosphatase 
treated with sialidase (neuraminidase, E.C. 3.2.1.18) (Ostrowski et al’ 
1976). 
Komoda and Sakagishi (1978) also demonstrated that the 
carbohydrate side chains of the ALP contain the sequence similar to 
"sialic acid-galactose-N-acetylglucosamine" with the penultimate 
galactose residue, which reveals the secretory nature of the 
glycoproteins. Turnover studies have shown that the half-lives of the 
isoenzymes vary with a much lower value for the intestinal isoenzyme 
than that for the hepatic enzyme. It is possible that, as in many secretory 
glycoproteins, the degradation of the ALP isoenzymes is carried out by 
the reticuloendothelial route (Gregoriadis et al, 1970; Morell et al 1972; 
Hugin et al, 1974). 
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1.1.2 The Properties of Alkaline Phosphatases 
The alkaline phosphatase isoenzymes exhibit different 
properties when subjected to various treatments. Due to the different net 
molecular charges and the sizes of the molecule, the alkaline 
phosphatase isoenzymes exhibit different electrophoretic mobilities. 
When the five isoenzymes are subjected to starch gel electrophoresis, 
two zones are frequently observed, a more anodal main zone and a low 
mobility, high molecular weight minor zone (Moss, 1982). The presence , 
of minor zone represents the aggregation of other proteins, membrane 
lipids with the ALPs leading to a larger sizes of the molecules, thus 
retarding migration in the starch gel. Among the five isoenzymes, 
1
 Catalytlcally similar Catalytically simitar 
• I ^ ~ - ~ I I ' 1 
NR - Neuraminidase! ffijRH . n 
r6S,Stant
 1 _ _ SS 
H L " " 1 
Similar in flU I B l Allelic 
catalytic and ^ ^ variation and S.m la In 
mm m rnammmmt » mm mm • • saw • • mrnmmmmm • • • mmmmmmmrn mtmmmmmt m mrnmrn^m • mm^m 
Includes components ( mmmm •" 
with higher m.w. - M i ' L " " " " N R - B H S S 
than main zones l - • _ • 
Bone liver Kidney Small Placenta 
I , intestine j 
Small but significant stability differences Very stable 
I — r - 1 L—r—1 L - r — J 
Mainly antiqenically similar Antiqenically Antigenically 
riistinct distinct 
Fig 1-3 Diagrammatic summary of differences in properties between 
multiple forms of human alkaline phosphatase. Some of these (eg 
Dlacental vs non-placenta phosphatases originate at the level or tne 
S S S qene others are probable the result of post-translationa 
S S S L n forms shown are based on those separated by starch-gel 
electrophoresis. (Moss, 1982) 
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placental enzymes show allelic variation resulting in three bands (Fig. 
1-3). The difference in mobilities may probably be due to the different 
contents of the negatively charged sialic acid since the desialated forms 
have identical isoelectric point. 
Different properties are expected in the isoenzymes originating 
from distinct gene locus. It can be inferred from the very marked 
stability of the placental isoenzymes towards heat treatment at 65°C. 
The placental isoenzyme is completely stable at this temperature 
whereas the other isoenzymes, especially those arising from bone, 
kidney and liver, show different degree of inactivation by heat. The very 
different thermostability observed in the placental isoenzymes is thus 
thought to be due to the difference in the primary sequence of the 
enzyme. 
Such difference in the primary sequence leads to the fact that 
they are also antigenically different. It has been observed in the 
placental and the non-placental isoenzymes. The sharing of some 
antigenic determinants between the placental, and the intestinal isoform 
results in the cross reactions of these two isoenzymes with the whole 
antisera (Boyer, 1963). 
“ The placental enzyme also differs from the non-placental 
enzymes by many catalytic properties as they show different relative 
rates of hydrolysis towards various orthophosphates and pyrophosphate 
substrates, and greater degree of inhibition by L-phenylalanine and lesser 
inhibition by L-homoarginine or levamisole (Ahmed and King, I960; 
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Table 1-1 Qualitative Properties of ALP Isoenzymes 
Source Heat Stability (65°C) Inhibitors 
L-Phe L-Homo L-PGG 
Liver Labile R I R 
Bone Labile R I R 
Placenta Stable I R I 
Intestine Labile I R R 
L-Phe: L-Phenylalanine R: Resistant 
L-Homo: L-Homoargininc I: Inhibited 
L-PGG: L-Phenylalanylglycylclycin 
Van Belle, 1976; Moss et al 1961). The different properties of the 
alkaline phosphatase isoenzymes are summarized in Table 1-1. 
1.1.3 Serum Alkaline Phosphatases 
Serum from normal, healthy subjects always contain at least 
two isoforms of ALP, the liver and the bone ALP as detectable by 
electrophoresis or selective-inactivation techniques. The presence of the 
alkaline phosphatases, or generally speaking, any enzymes, in the serum 
is a result of the synthesis and release of the enzymes into the circulation 
by the organs involved. Their levels in the serum reflect the balance 
between the rate of synthesis and release into serum during cell turnover 
and the rate of clearance from the circulation. Increased serum levels of 
enzymes result from the proliferation of cells, an increase in the rate of 
cell turnover, cell damages or induction of enzymes, or reduced 
clearance. The low levels may be due to reduced synthesis, or to 
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congenital deficiency or the presence of inherited variants of relatively 
low biological activity (Zilva et al, 1988). 
1.1.3.1 Intestinal Alkaline Phosphatase 
The isoenzyme analysis of serum has shown that small amount 
of intestinal ALP can be found in about 25% of normal sera, most of 
which pertaining to the subjects of B- or O-blood group who are 
secretor-positive. This isoenzyme has been shown to increase 
postprandially in those whose serum shows detectable isoenzyme 
(Langman et al’ 1966). The low level of this isoenzyme in normal serum 
is accounted for by its clearance from the circulation at a significantly 
higher rate than the other isoenzymes (Domar et al, 1988). Pathologic 
increases of the serum intestinal ALP are observed in various diseases of 
the digestive tract, liver cirrhosis, intrahepatic cholestasis and those 
patients undergoing chronic hemodialysis (Dent et al 1968; Stolbach et 
al, 1967; Walker, 1974; Domar et al’ 1988; Jain et al, 1986). 
s 
11-^.2 Placental Alkaline Phosphatase 
Placental alkaline phosphatase, derived from syntrophoblasts, 
becomes detectable in serum of pregnant women in 16th to 20th weeks 
of gestation and increase progressively up to ohset of labor. They 
disappear within 3 to 6 days of the delivery of the placenta. 
Complications of pregnancy such as hypertension, pre-eclampsia and 
eclampsia are always reflected in elevated serum level of placental ALP 
(Hunter et al, 1970; Aleem, 1972). High level of serum placental ALP 
were sometimes found in patients with cholestatic liver diseases (Domar 
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et al, 1988). The inability of the placental ALP to cross the placenta 
renders the amount of this enzyme in the serum of newborn infant 
.4 . 
undetectable. 
1.1.3.3 Renal Alkaline Phosphatase 
Renal alkaline phosphatase is present in particularly high 
concentration in renal tubules and is absent in serum in normal healthy 
subjects (Zilva et al, 1988). Renal diseases also rarely lead to serum 
renal isoform but it has been observed during rejection of the renal 
transplant. 
1.1.3.4 Skeletal Alkaline Phosphatase 
The bone and liver ALPs are invariably present in serum. The 
bone-specific alkaline phosphatase is synthesized and secreted into the 
serum by the bone forming cells of the skeletal organ - osteoblasts. The 
bone-specific ALP has 
600 - . 
long been considered as _ Bone phosphatase 
an index of osteoblastic _ — 
I 400 
activity with an increased ^ 
I 300 - 1 
serum level of bone- ! \ 
specific ALP and an 1 200 | . .. _ _ _ 
increased osteoblastic 100" _ " “ _ “…j""" ;;| 
activity. The normal 0 | 1 ~ n 1 1 1 1 1 ~ 
10 20 30 40 50 60 70 80 
serum level of bone-
 Age (years) 
specific ALP is dependent
 R g ^ changes in the relative activities of 
o i 4 a h o u t • bone and liver alkaline phosphatases in 
on age (Fig. 1-4) at about
 h u m a n s e r Um with age. (Moss, 1982) 
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4 times higher in puberty than in adult. This physiologic increase in 
puberty reflects the higher osteoblastic activity which is essential for 
adolescent growth spurt of bone. After the growth spurt, the serum level 
of bone-specific ALP drops to a low level, about 50 IU/L and shows a 
steady rise throughout the life. Pathologic increase of serum bone-
specific ALP are observed in osteomalacia and rickets, Paget's disease of 
bone, various malignant tumors possessing osteoblastic activity such as 
osteogenic sarcoma and secondary deposits of carcinoma in bone (Zilva 
et al, 1988). Increase in osteoblastic activity is also observed in bone 
fracture, thereby, increasing serum level of bone-specific alkaline 
phosphatase. 
1.1.3.5 Hepatic Alkaline Phosphatase 
As shown in Fig. 1-4, normal serum level of the hepatic ALP 
increases steadily throughout life. The hepatic ALP is found in high 
concentration in the hepatobiliary tract, the diseases of which, therefore, 
always leads to the high level of the hepatic ALP in serum, e.g., intra- or 
extrahepatic cholestasis. 
1.1.3 6 MisrpTlaneous Alkaline Phosnliatases 
The sera from patients with hepatobiliary disease show a low 
mobility band in starch gel or polyacrylamide gel electrophoresis. In 
non-sieving media such as cellulose acetate, it migrates towards the 
anode than the main liver band and it has been termed the ”fast liver" or 
•»ai liver" fraction (Moss, 1982). This kind of ALP has been shown to 
be the hepatic enzyme in nature associating with fragments of cell 
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membrane from biliary tract cells or hepatocytes. It has been termed 
biliary alkaline phosphatase, releasing into the blood as a result of cell 
damage (De Broe et al, 1975). 
Another kind of ALP is found in sera from many patients 
suffering from malignant diseases. Reports have demonstrated that the 
serum samples of some patients with hepatoma show a more anodal 
band than the main hepatic ALP in gel media. This band is inhibited by 
L-phenylalanine and is more resistant to heat; thus resembling placental 
isoenzymes. Some of these carcinoplacental isoenzymes, together with 
the Regan isoenzymes, may be indistinguishable from the normal 
placental ALP, which can be accounted for by derepression of the 
placental isoenzyme gene by the malignant cells. The placental ALP has 
been shown to be inducible by prednisolone and sodium butyrate in the 
culture of HeLa S3 cell line (Chou and Takahashi, 1987). 
Carcinoplacental ALP may sometimes be detected at pre-malignant 
conditions (Nathanson and Fishman, 1971); however, it is of little 
diagnostic value merely based on the demonstration of placental-like 
ALP in serum. 
Another t u m o r associating ALP isoenzyme different from the 
Regan and Nagao isoenzymes, viz. the variant ALP, has been 
demonstrated in the«sera of hepatocellular carcinoma-bearing patients in 
Southern African blacks (Bukofzer et ah 1988). This isoenzyme is more 
prevalent in Western and Japanese patients. 
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1.1.4 Problems in Discriminating the Skeletal and Hepatic 
Alkaline Phosphatase in Serum 
Elevated serum levels of ALP are observed in many disease 
status, as previously described. Therefore, identification of the ALP 
isoforms that contribute to the raised serum level is important in 
diagnosis of many diseases, together with other biochemical parameters. 
Identification of the placental and intestinal isoenzymes from the TNS-
ALPs is quite straight forwards by exploitation of their thermostability 
and their different catalytic properties towards various substrates (Table 
1-1). However, the distinction between hepatic and skeletal isoforms is 
not easily achieved due to their similar catalytic properties towards 
various substrates and inhibitors, probably as a result of the translation 
from the same genetic locus. The great majority of the requests for the 
isoform analysis also aims at distinguishing the bone and liver as 
alternative or coexisting sources of the elevated ALP activity in serum. 
Electrophoresis is suitable for qualitative detection of the 
enzyme; nevertheless, the incomplete separation of the skeletal and 
hepatic isoforms makes the densitometric quantification of the enzymes 
difficult (Moss, 1982; Behr and Barnert, 1988). Afterall, it is suitable to 
measure biliary and intestinal ALP (Rosalki and Foo, 1984). The simple 
heat inactivation as ay will give only qualitative or semi-quantitative 
estimates of the bone-specific ALP, in which a residue activity of less 
than 20% after heat treatment at 56°C for 10 minutes reflects the 
presence of skeletal isoform in a larger proportion (Whitby and Moss, 
1975). The improved sequential heat inactivation method at 56°C will 
i •
 t .. 
give quantitative estimates of the bone-specific ALP but it is too tedious 
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to perform and the calculation involved is quite complicated; therefore, it 
is impractical for large scale, routine analysis of the samples in clinical 
laboratories (Whitby and Moss, 1975). 
1.1.5 Wheat Germ Lectin Precipitation of the Bone-Specific 
Alkaline Phosphatase 
Rosalki and Foo in 1984 first introduced a method to quantify 
serum bone-specific ALP by the use of a carbohydrate binding protein of 
plant origin, wheat germ lectin from Triticum vulgaris. It specifically 
binds to the N-acetylglucosamine residues and its derivatives, e.g., N,N'-
diacetylchitobiose (Allen et al, 1973) of the carbohydrates side chains of 
many glycoproteins. After binding to the sugars, its large molecular 
weight leads to the precipitation of the large lectin-glycoproteins 
complex. Since ALP isoenzymes are N-acetylglucosamine-containing 
glycoproteins, they have been demonstrated to be capable of being 
bound by wheat germ lectin with the skeletal isoform being 
preferentially bound. A higher content of N-acetylglucosamine in 
hepatic isoform (30 moles per mole of enzyme) than the intestinal 
isoenzyme (15-20 moles per mole of enzyme) permit the binding of 
wheat germ lectin to the hepatic enzyme (Komoda and Sakagishi, 1978; 
Crofton, 1987). The sugar composition of skeletal ALP has not been 
directly studied but the very strong binding to the wheat germ lectin 
reflects its even higher content of N-acetylglucosamine than the hepatic 
isoform rendering the percentage binding of hepatic isoform to the wheat 
germ lectin insignificant when coexisting with the skeletal isoform. 
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The method described by Rosalki and Foo involved a 
precipitation of the skeletal isoform with wheat germ lectin and 
reconstituted the precipitate for the skeletal ALP assay, together with the 
assay of total ALP in plasma sample, the hepatic isoform being 
calculated from the difference between the two values. The liver 
fraction, or the supernatant, comprises mainly the hepatic isoform; 
however, it also contains intestinal or placental isoenzymes, if any. 
They also demonstrated that around a quarter of the high-molecular-
weight biliary ALP would be co-precipitated as the skeletal fraction, 
which could be avoided by the pretreatment of the sample with Triton X-
100. The function of Triton X-100 surfactant is to solubilize the 
membrane fmgment of the biliary ALP, thus converting them into the 
hepatic isoform. In addition, Rosalki and Foo reported that the skeletal 
isoform precipitated was only 80% of the total skeletal isoform present. 
This has been disproved by Behr and Barnert in 1986 by their 
demonstration of complete precipitation of ALP activity (^98-99%) by 
using cord sera which are shown to contain only skeletal ALP activity. 
The partial precipitation of the skeletal isoform by Rosalki and Foo may 
be due to the batch variation of the wheat germ lectin they purchased. 
Rosalki and Foo also described another method for the separation of the 
skeletal isoform from the non-skeletal isoforms, namely affinity 
electrophoresis, by presoaking the cellulose acetate membrane with 
buffer including wheat germ lectin before electrophoresis. This method 
had b e e n demonstrated to separate the skeletal isoform from the hepatic 
isoform, which could not be resolved completely in conventional 
unmodified method. 
14 ' 
Introduction Bone Structure & Calcification 
1.2 STRUCTURE OF BONE AND MECHANISMS OF 
CALCIFICATION (Little, 1973; Urist, 1980) 
For many years bone had been regarded as nonvital tissue in 
the body. Much researches, however, have recently been carried out to 
show that bone is indeed living materials despite the much lower 
metabolic rates and cellular activities comparing with other tissues. 
Bone tissue is the most complex of all the building materials of the body. 
Bone has dual properties, mechanical property and metabolic property, 
which are closely dependent on its structure and composition. Bone may 
be classified into two major types: (1) flat bone or membrane bone; and 
(2) tubular bone or endochondral bone. The bones of the cranial vault, 
face and clavicle are the typical flat bones whereas tubular bones (long 
bones) refer to the bones of the appendicular skeleton, vertebral column 
and the base of the skull, e.g., tibia, femur, ulna, humerus, etc. Three 
parts can always be identified in tubular bone: epiphysis, metaphysis and 
diaphysis. 
1.2.1 Gross Structure of Bone 
Fig. 1-5 is the diagrammatic representation of a typical long 
bone or tubular bone. The three parts can clearly be identified; the 
epiphysis situated sit both ends of bone, the metaphysis next to the 
epiphysis and the middle portion of the bone, diaphysis or bone shaft. 
Epiphysis consists of a core cancellous bone or spongy bone 
and the peripheral cartilage tissue. The outward articular cartilage is 
bathed in synovia which is responsible for absorption of any vibration 
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generated during motion. The — Articular 
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Cancellous bone next to the I M ^ J p l . 
growth plate is a result of Epiphysis 
endochondral ossification. The -
-l lular arrangement in the growth 
plate enable the calcification to assocla ted — bone tissue ' (Urist' 1980) 
occur in a columnar form resulting 
in many large beam-like pieces, trabeculae. So cancellous bone is also 
called trabecular bone or spongy bone. Compact bone in diaphysis has 
been remodeled in a large extent from the cancellous bone. The bone 
structure in the compact bone in diaphysis is regular, highly organized 
lamellar type which is much stiffer than the cancellous bone and capable 
of tolerating the deformational forces from weight-bearing. 
The compact bone is not solely made up of bone materials; 
blood vessels, nerves, muscle and tendon inser t ion .can penetrate into the 
compact bone to provide nutrients for the living bone cells and a site of 
attachment for muscle. The outermost surface of the diaphysis is the 
periosteum and the inner surface of the compact bone next to the bone 
marrow is the endosteum. These are made up of fibrous undifferentiated 
mesenchymal cells. While the epiphyseal growth plate is responsible for 
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the longitudinal growth of the bone, periosteum and endosteum are 
responsible for the growth of bone in diameter with the bone formation 
on the periosteal side and bone resorption from the endosteal side. Bone 
marrow is composed of hemopoietic and stromal tissue and is usually 
not considered as a part of skeletal tissue. 
1.2.2 The Elements of Bone 
Bone is made up by living cells and non-living extracellular 
materials including organic matrix and inorganic calcium phosphate 
crystals. 
1-2.2.1 Rone Cells 
Osteoblasts: 
Osteoblasts are the bone forming cells of the skeleton. The 
functions of osteoblasts are mainly synthesis and secretion of all organic 
components of bone matrix. In addition, they are believed to play a role 
in the initiation of mineralization and modulation of electrolyte fluxes 
between the extracellular fluid and bone fluid. Recent researches have 
also demonstrated that osteoblasts release local factors mediating bone 
resorption. Osteoblasts are derived from osteoblast progenitor cells 
which in turn are derived from the undifferentiated mesenchymal cells of 
the periosteum. Therefore, osteoblasts are mainly found on the osteoid 
of bone surface. The cytoplasm of osteoblasts actively synthesizing 
organic bone matrix are basophilic due to the higher content of RNA and 
ribosomes essential for bone matrix synthesis. Mineralization rapidly 
occurs once organic matrix are secreted. Osteoblasts contain long 
.
1 7
 . ' • 
Introduction Bone Structure & Calcification 
cytoplasmic processes with a swelling end, called matrix vesicles. 
Matrix vesicles have been shown to contain high concentration of 
alkaline phosphatase which has long been thought to be involved in 
“ • i -
initiation of calcification. Osteoblasts have also been demonstrated to be 
responsive for various hormones, e.g., parathyroid hormone. 
Osteocytes: 
After matrix secretion and mineralization, the osteoblasts 
themselves become buried into the wall of calcified matrix and 
differentiate into osteocytes. They occupy a small cavity of the calcified 
matrix, called lacunae, and communicate with the other osteocytes by 
very tiny cytoplasmic processes, the canqliculi, between the adjacent, 
concentrically arranged lamellae. Morphologically, osteocytes contain 
reduced amount of cytoplasmic organelles relative to osteoblasts, e.g., 
reduced number of rER, Golgi complex, secretory vesicles, 
mitochondria. The major function of osteocytes is to maintain the 
vitality of bone by the slow rate of metabolism. Osteocytes have been 
shown to release citrate, lactate, collagenase and lysosomal enzymes 
leading to the erosion or "resorption" of bone around osteocytes, the so-
called "osteocytic osteolysis". 
Osteoclasts: 
Osteoclasts' are responsible for bone resorption. Osteoclasts 
are readily recognized by their larger size and multiple number of 
nucleus as a result of cell fusion of their precursor cells. They have large 
number of mitochondria. Osteoclasts are derived from cells different 
from the osteoblast-osteocyte lineage. They are thought to be derived 
from the hemopoietic stem cells. Osteoclasts are actually the result of 
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the fusion of monocytes undergoing diapedesis from the vasculature into 
appropriate bone sites. Active osteoclast consists of hundreds of 
microvilli forming the brush border directed at the resorbing surface of 
the bone. The resorbed bone materials, e.g., the matrix and calcium 
salts, are engulfed by the invagination of the cell membrane between 
microvilli of the brush border in such a way that a series of vacuoles are 
formed. 
1.2.2.2 Organic Substances of Bone 
Apart from cells, bone contains large proportion of organic 
substances. They are mainly synthesized and secreted by the 
osteoblasts. The organic substances of bone may be collagenous or non-
collagenous. 
Collagen constitutes about 90% (w/w) of the organic materials 
‘ L ; . . . , . 
Table 1-2 Types of collagen (Urist, 1980) 
HYDROXYLYSINE 
RESIDUES / l(f CARBOHYDRATE 
MOLECULAR AMINO ACID (% HYDROXYLYSINE 
TYPE FORMULA TISSUE RESIDUES GLYCOSYLATED) 
I [a l(I)]2a2 Bone, dentine, skin, 
"* tendon, blood vessel 6>8 <20 
wall, gastrointestinal 
• tract 
II [all]3 Cartilages 20-25 • 50 
III [aIII]3 Skin, blood vessel 
wall, synovial 
membrane, 6-8 15-20 
gastrointestinal tract, 
dentine 
IV [aIV]3? Basement membranes 60-70 80 
V [aB]2aA? Basement membranes 6-8 2 0 
_ 
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of the extracellular matrix. Bone organic matrix is consisted of type I 
collagen which has two identical a chain denoted as a x chain and 
another a chain with a slightly different amino acid composition, 
denoted as 0¾ chain. Table 1-2 shows the types of collagen and their 
distribution in the body tissue. 
The two a i chains and the a 2 chain are coiled together in a 
super helix to form a rope-like triple helical structure, the tropocollagen. 
Tropocollagen molecules are arranged in such a regular structure that 
there is slight overlapping between the head of one tropocollagen 
molecule and the tail of another molecule. This results in the 
observation of regular striated structure of collagen fibril in electron 
microscope. The striations originate from the 'overlap zone' and the 
'hole zone' of the collagen fibril. Collagen is synthesized in the 
osteoblasts in a precursor form. Direct translation of mRNA results in 
protocollagen molecules which undergo hydroxylation and 
glycosylation to form procollagen • The procollagen is secreted into the 
extracellular space where they are subjected to procollagen peptidase 
removal of the C- and N-terminal extensions resulting in tropocollagen. 
Regular aggregation of tropocollagen fibers undergoes fiber and cross-





Noncollagenous substance make up the rest of the organic 
matrix in compact bone. They are mainly noncollagenous proteins, 
smaller proportions of proteoglycans and lipids. They include various 
sialoproteins with high content of sialic acid r e s i d u e s , phosphoproteins 
with phosphate group esterified with serine residues of proteins, y-
l .:;: - : . .. '-.. ^ ' ' • ‘ ‘ ” 
“V.,...... : . “:...., ...: '^ '} . ..' • • ‘ . . . . . .... . . ‘ . . . . . . . 
2 0 
f …. ‘’ . . . ‘ , • ' 
Introduction Bone Structure & Calcification 
carboxyglutamic acid-containing proteins, e.g., osteocalcin, plasma 
proteins such as albumin derived from the vasculature penetrated inside 
the compact bone and other biologically active peptides as various bone-
derived growth factors. 
1.2.2.3 Inorganic Substances of Bone 
Majority of the inorganic substances of bone are the various 
form of calcium phosphate crystals. Others such as calcium carbonate 
contribute to a very minute proportion. Several kinds of calcium 
phosphate can be prepared in the laboratory or isolated from bone as 
listed in Table 1-3 in the order of decreasing acidity, decreasing 
solubility and increasing thermodynamic stability. As shown in the 
table, hydroxyapatite is the most stable form of calcium phosphate and is 
the main form of crystal found in bone. Any kinds of calcium phosphate 
formed by mineralization of bone matrix are all transformed into the 
most stable hydroxyapatite crystal successively. 
Table 1-3 Calcium and phosphate compounds (Urist, 1980) 
* — — ~ “ _ M O L A R 
FORMULA NAME Ca/P ABBREVIATION 
Ca(HPO«).2H,0 Dic^lcium phosphate dihydrate 1.0 DCPD 
» 1 QO O P 
Ca4H(P04)3 Octacalcium phosphate ^ ^ ^ ^ 
Ca9(P04)6 (Var.) Amorphous calcium phosphate 1.3-1.5 ACP 
Ca3(P04)2 Tricalcium phosphate 1.50 TCP 
Ca5(P04)30H Hydroxyapatite L 6 6 
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1.2.3 Mechanisms of Calcification 
Two mechanisms have been proposed for the initiation of 
mineralization of bone, the booster mechanism and the catalytic 
nucleation mechanism. 
Booster mechanism involves the action of alkaline phosphatase 
which hydrolyses phosphorylated substrates in the bone fluid to liberate 
inorganic phosphate group. This results in the elevation of the ionic 
product of calcium and phosphate above the critical point, 6 mM2; 
spontaneous precipitation of calcium phosphate crystal occurs. This 
mechanism is supported by the presence of extremely high concentration 
of alkaline phosphatase in the matrix vesicles of osteoblasts which are 
the sites for initiation of mineralization. 
The catalytic nucleation mechanism causes a nucleus or seed 
to form from the bone fluid, thereby initiating the deposition of calcium 
phosphate on the seed. Bone fluid and serum is metastable with respect 
to calcium and phosphate ions, ionic product being 1.3 mM2; in other 
words, the concentration is below the saturation needed for spontaneous 
precipitation and yet well above the saturation needed to support 
successive growth of crystal once seed has been formed. 
i 
• 
Collagen is one of the nucleation system involved. Calcium 
phosphate deposits on the 'hole region1 of the mature collagen fiber and 
then deposition continues until all space of the collagen fiber is filled 
with the calcium phosphate crystal as if the collagen fibers were bathed 
in the sea of calcium phosphate deposits. Apart from collagen, the 
i f ' • .. :. ‘ . 
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\ 
aforementioned matrix vesicles are the effective nucleators due to the 
presence of preformed amorphous calcium phosphate. Other nucleating 
agents include tendons, phospholipids, proteolipids, phospholipid-
calcium phosphate complex, lysozyme, phosphoryn, noncollagenous 
proteins, elastin and so forth. 
Since hydroxyapatite crystal possesses the autocatalytic 
property to cause the deposition of calcium phosphate in the metastable 
bone fluids, a problem of uncontrolled growth of the calcium phosphate 
arise. Fortunately, many inhibitors on the growth of calcium phosphate 
prevent us from turning into pillars of hydroxyapatite. The inhibitors 
prevent either further nucleation or the growth at uncontrolled rate of 
already formed nuclei. Various ionic substances can serve as inhibitors 
of bone deposit, such as Mg2+, citrate, pyrophosphate, other 
polyphosphate as GTP, ADP, ATP, etc., nonphysiologic substances as 
Sr2+, tetracycline, phosphoryn, lysozyme and osteocalcin. Alkaline 
phosphatase may also cause the bone formation by hydrolyzing the 
phosphorylated inhibitors thus leading to the deposition of calcium 
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1.3 BONE FRACTURE HEALING (Adams, 1978; Urist, 1980) 
1.3.1 Types of Fracture 
The definition of bone fracture is an abrupt break of the 
calcified structure of a bone caused by an extrinsic or intrinsic 
mechanical force. Etiologically, bone fracture can be classified into 
three main types: traumatic fracture, stress or fatigue fracture and 
pathologic fracture. Traumatic fracture is caused by direct violence on 
the bone or indirect violence transmitted along the bone. Fatigue 
fracture is caused by repetitive stress imposed upon the bone. The bones 
affected by this fracture are confined in the lower limb, e.g., metatarsals 
of the foot, the shaft of tibia or fibula and sometimes the neck of femur. 
The bones suffering from pathologic fracture have already been 
weakened by diseases like osteoporosis and some endocrine disorders, 
e.g., osteomalacia. The fracture is open when there is direct 
communication between the fracture site and the exterior of the body; 
otherwise, the fracture is closed (Fig. 1-6). Infection is likely occurred 
in the former case whereas the latter is apparently free from that risk. 
In terms of ‘ . 
WM ISM 
PATTERN'FRACTURES CAN BE M 
: : . d % I : 
transverse, oblique, 
spiral, comminuted, ^ ^ 
compression and a-
greenstick fractures (Fig. Fig. 1-6 (a) Open fracture and (b)closed fracture 
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1-7). Angulation force and twisting forces are the causes of transverse 
and spiral fracture respectively. The oblique surface of the oblique 
fracture as well as spiral fracture tends to be displaced by the elastic pull 
of the muscle. Comminuted fracture is characterized by having two or 
more bone fragments. Compression fracture mostly occurs in the 
vertebral body whose structure is crushed almost to powder and cannot 
be restored fully to its original form. Greenstick fracture is incomplete 
fracture occurring only in the resilient bone in children. 
. . ‘ 
. * \ 
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(E) (F) 
Fiq 1-7 Common patterns of fracture. (A) Transverse fracture; (B) Oblique 
fracture* (C) Spiral fracture; (D) Comminuted fracture; 
(E) Compression fracture; (F) Greenstick fractures. Modified from 
Outline of Fractures, Adam, 1978. 
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1.3.2 The Process of Bone Fracture Healing 
A fracture begins to heal as soon as the bone is broken. 
Healing proceeds through a number of stages until the bone is 
consolidated if conditions are favorable. In a tubular bone, usually five 
stages can be identified. They are the stages of hematoma, subperiosteal 
and endosteal cellular proliferation, fibrocartilaginous callus, bony callus 
or consolidation and remodeling (Fig. 1-8 a/b). During these stages, 
different tissue types develop orderly. 
1.3.2.1 Stage of Hematoma 
This stage occurs immediately to 24 hours after the bone has 
been fractured. The very first response is to form a blood clot around the 
fracture site. The blood clot is the result of damage to the blood vessels 
in the bone marrow, periosteum, endosteum and the capillaries in the 
harversian canal. The portion of the bone about 1 cm apart from the 
fracture site is devitalized and will subsequently be resorbed. Repair of 
the periosteum, if damaged, is firstly achieved. Then the cellular 
proliferation of the cambium layer, the most inner part of the periosteum 
immediately next to the calcified bone shaft, gives rise to fibroblasts 
leading to the granulation of the hematoma. Devitalized muscles around 
the fracture site will undergo autolysis within 5 to 10 days. Bone 
fragments will be resorbed or remodeled and bone marrow deprived of 
their blood supply undergo fatty degeneration. 
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(A) Stage of Hematoma 
Periosteum 
Blood Clot 
(B) Stage of Cellular Proliferation 
_ — Subperiosteal 
rviiiiinr 
Proliferation 
• • • • • • • • • • • • • • 
• , • i ' • 
(C) Stage of Fibrocartilaginous Callus 
Dead Bone 
‘— Sbed 
Fig. i -8a Stages in the healing of a fracture. (A) Stage of hematoma; 
(B) Stage of subperiosteal and endosteal cellular proliferation; 
(C) Stage of fibrocartilaginous callus. (Modified from Outline of 
Fractures, Adams, 1978) 
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1.3.2.2 Stage of Subperiosteal and Endosteal Cellular Proliferation 
This stage occurs at the second day of the post-fracture time. 
Organization of blood clot is observed in this stage. The cambium layer 
continues to proliferate to give out osteoblasts and chondroblasts, in 
addition to fibroblasts. Moreover, some cells in the bone marrow with 
osteogenic potential, the osteogenic precursor cells, differentiate into 
osteoblasts. 
1.3.2.3 Stage of Fibrocartilaginous Callus 
This stage happens on the forth day of the post-fracture time. 
During this stage, chondroblasts and osteoblasts begin to lay down 
collagen fiber. Collagen secreted by chondroblasts is type II similar to 
the type found in cartilage. The callus in this stage contains large 
amount of glycosaminoglycan as the ground substances. Osteoclasts 
appear in this stage for the resorption of dead bone. The functioning 
enzymes in this and the former stages are mainly the anaerobic 
glycolytic enzymes since oxygen tension of the fracture sites in these 
stages is rather low. Angiogenesis gradually occurs favoring the 
osteogenesis in the later bony callus stage at high oxygen tension. In the 
later stage of the fibrocartilaginous callus, the content of. 
glycosaminoglycan begins to reduce. The collagen type is gradually 
changed from type II into type I and type III and deposition of 
hydroxyapatite crystals begin to occur to form the temporary woven 
bone. This leads the callus into the bony callus stage. 
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(C) Stage of Fibrocartilaginous Callus 
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(D) Stage of Bony Callus 
(E) Stage of Remodeling 
^
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^ ^ ^ ^ ^ ^ ^ ^ ^ Sled 
Fig l-8b Stages in the healing of a fracture ( C ^ 
9
 fibrocartilaginous callus; (D) Stage of bony callus (E) S t a g e oT 
remodeling (Modified from Outline of Fractures, Adams, 1978.) 
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1,3.2.4 Stage of Bony Callus 
This stage occurs around 5 to 10 days of the post-fracture time. 
The fibrocartilaginous callus is totally replaced by bone in this stage; 
therefore, this stage is also called the stage of consolidation. The 
chondroblasts in the former fibrocartilaginous callus are directly 
converted into osteocytes or indirectly through osteoblasts. The early 
bony callus is composed mainly of woven bone whose collagen fibers 
are thin, irregular and unorganized. The hydroxyapatite crystals deposit . 
rapidly and so they have lower density. Woven bone is also found in 
many osteogenic malignant tissue, e.g., osteosarcoma, which form bone 
at a rapid rate. In the later stage of bony callus, woven bone is 
subsequently replaced by lamella bone which is the mature bone type 
found in the compact, living bone. The collagen fibers in lamella bone 
are thick, regularly organized and is deposited slowly with high density 
hydroxyapatite. The displacement of woven bone by lamella bone is 
mediated by osteoclasts which resorb the woven bone first leaving more 
room for the new lamella bone deposited by osteoblasts. Due to the 
angiogenesis, the oxygen tension in this stage is higher favoring the 
osteogenesis. The functioning enzymes in this stage are therefore those 
of the aerobic glycolytic enzymes (enzymes in the TCA cycle). Also the 
concentrations of lysosomal enzymes, inorganic pyrophosphatase and 
alkaline phosphatase increase in this stage probably responsible for 
mineralization. 
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1-3.2.5 Stage of Remodeling 
This is the final stage of bone fracture healing and occurs after 
30 days of the post-fracture time. In this stage, woven bone is totally 
replaced by lamella bone. Continuous resorption by osteoclasts and 
deposition of new lamella bone by osteoblasts are carried out until a 
bone marrow cavity is reformed and finally remodel the bone into its 





1.4 THE OSTEOBLASTIC CHARACTERS OF UMR-106 
OSTEOSARCOMA CELL LINE 
» ,.4 * ‘ 
As in other body tissue, bone cells can also show malignant 
transformation. Some of them are capable of laying down bone 
substances at an uncontrollable rate resulting in a large calcified bulb in 
the bone. Such kind of tumor always synthesizes and secretes large 
amount of alkaline phosphatase. They have been termed osteosarcoma, 
the bone-forming tumor. ‘ 
1.4.1 Classification of Osteosarcoma 
Osteosarcoma is currently characterized by having high ALP 
activity in the tumor cells. It is histologically classified into four types, 
the osteoblastic, chondroblastic, fibroblastic and telangiectatic (Table 1-
Table 1-4 Immunohistochemical Findings in Different Types of 
Osteosarcoma in Comparison with Other Chondroid Tissue 
Osteosarcoma 
— — Chondrosarcoma Cartilage 
Fibro. Osteo. Chondro. Telang. 
Collagen I + + + + + / " + + 
Collagen I I - - + + “ + + + + + 
Collagen I I I + + + / " “ , 
S-100 - - + + + 
ALP ++ +++ ++ + + “ “ 
+ + + : markedly positive + / - : P o s i t i v e c e U s r a r e ^ s e e n 
+ + : moderately positive _ negative 
+ : slightly positive 
Yoshida et al Acta Pathol Jpn (1988) 38 (3) 325-338 
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4) (Yoshida etal, 1988). 
Table 1-4 shows that only osteosarcoma expresses ALP 
activity and the highest amount is found in the osteoblastic type. Type I 
collagen and trace amount of type III collagen are synthesized by the 
osteoblastic osteosarcoma, which is also found in normal osteoblasts. 
The expressions of type II collagen mainly and S-100 protein by the 
chondroblastic type reveal its chondroid nature as in chondrosarcoma 
and cartilage. 
1.4.2 Derivation of UMR-106 Osteosarcoma Cell Line 
UMR-106 osteosarcoma cell line was 32P-induced rat tumor. 
Induction of tumor was achieved by injecting 32 P-orthophosphate 
intraperitoneally into the inbred Sprague-Dawley rats, A palpable tumor 
was developed 6 - 9 months later around the knee joint of distal femur. 
The induced tumor was removed and prepared single cell suspension 
which was then injected into the left flank subcutaneously of the 
recipient rats of the same strain. After growing to appropriate size, the 
transplanted tumor was passed to another rat. The tumor was maintained 
every 3 - 4 weeks for 3 years (Ingleton et al, 1977). 
The transplantable tumor was then rerpoved and single cell 
suspension was prepared for in vitro culture. The single cell suspension 
was grown in double layer nutrient agar system for 14 days at 37°C. 
When individual clone was visible, the clone was picked up and cultured 
with liquid media. Confluent monolayer was subcultured and the UMR-
106 cell line derived (Patridge et al’ 1980). 
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1.4.3 Osteoblastic Characters of UMR-106 
* . i ‘ • 
The radiation induced transplantable rat osteogenic sarcoma 
and the UMR-106 cell line belong to the osteoblastic type of 
osteosarcoma (Section 1.4.1). They retain many characters resembling 
the normal osteoblasts e.g., ALP secretion and responsiveness to PTH 
etc. 
I 
1.4.3.1 AT.P Expression 
The radiation induced osteogenic sarcoma have been shown to 
express high concentration of alkaline phosphatase. Besides, the ALP 
was also secreted into the serum of the rat which showed the parallelism 
between the size of the tumor and the serum ALP level (Ingleton et al, 
1977 1979). A drop of serum ALP activity was observed with the 
removal of the tumor. However, rats showing recurrent osteosarcoma 
led to the rise of serum ALP activity again. These evidences strongly 
suggested that the serum ALP activity was derived from the 
i' 
osteosarcoma (Ingleton et al, 1979). 
Ingleton et al in 1979 also demonstrated that the ALP secreted 
by the tumor was the bone isoform by the demonstration of the heat 
susceptibility at 56 C of the serum ALP. The heat inactivation profile of 
the serum ALP was similar to the skeletal ALP standard. 
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1.4,3.2 Hormone Responsive Adenylate CyjJaseJSy-Stem 
The radiation induced osteosarcoma and the UMR-106 cell 
line have been shown to retain the hormone responsive adenylate cyclase 
system similar to those found in the cell membrane of normal 
osteoblasts. They are responsive to prostaglandins (PGs) of the EL, Ej 
and F2ot types (Ingleton et al, 1977; Crawford et al, 1978). Apart from 
PGs, UMR-106 cells show abundant cell surface parathyroid hormone 
(PTH) receptors (Martin et al, 1976; Atkins et al’ 1977; Crawford et al, 
1978; Ingleton et al’ 1977 1979) which is saturable with increasing 
concentration of 125I-labeled rPTH-(l-34) in a time dependent manner 
(Kano et al’ 1991). Guanine nucleotide, guanylylimidodiphosphate 
[Gpp(NH)p], has also been found to reduce the maximum binding to 
59% in membrane assay (Mitchell et al, 1990). They also found that 
PTH stimulates adenylate cyclase (AC) in dose-dependent manner and 
the guanine nucleotide increases the basal activity of the PTH-stimulated 
AC activity. PTH receptors have also been demonstrated to be 
internalized by a receptosome-mediated pathway, degraded and released 
from the cell (Mitchell et al 1990). 
1 r y t o s n l i c Receptors for L2SJIihy_drQxyrhol alciferoI 
The UMR-106 cell line is also characterized by the retention 
of cytosolic receptors for 1,25 dihydroxycholecalciferol (1,25-DHCC) 
(Manolagas et al, 1980a/b; Klem et al, 1990) as the other relative clones 
of UMR-106, e.g., UMR-104, UMR-105 and UMR-108. The receptors 
were shown to possess affinity to DNA as the radiolabeled 1,25-DHCC-
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receptor complex could be adsorbed onto DNA-cellulose column 
(Partridge et al, 1980). 
’ • -i • 
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1.5 IN VITRO CULTURE OF FETAL RAT CALVARIAL 
OSTEOBLASTS 
Single cell suspension obtained from sequential collagenase 
digestion of the calvaria of rat fetuses has been shown to be viable in in 
vitro culture (Nefussi et al, 1985; Bellows et al9 1986). Other methods 
have been suggested such as migration of cells from fetal rat calvaria 
(Jones and Boyde, 1977; Ecarot-Charrier et al, 1983) mechanical 
techniques (Smith et al, 1973) or cloning from a mineralized matrix in 
vitro (Williams et al, 1980; Sudo et al, 1983). 
The primary culture of osteoblasts released by collagenase 
digestion is capable of laying down collagen fiber in the presence of 
ascorbic acid resulting in three dimensional nodules in the culture plate. 
In the presence of artificial substrates, sodium p -glycerophosphate, 
mineralization occurs on the three dimensional nodules which could be 
visualized by von Kossa staining techniques for calcium deposit. The 
number of nodules formed were dependent on the initial number of cells 
seeded. Dexamethasone caused a significant increase in the number of 
nodule formed (Bellows et al, 1986). Histological section of the nodules 
showed a woven bone-like structure. The collagen secreted was type I 
as stained by specific antibody. The cells covering the surface of 
nodules showed intensive staining for alkaline phosphatase. The cells 
released in the early digestion period were osteoclastic while those 
released in the later stages of digestion were more osteoblastic as they 
exhibit responsiveness to PTH, PGs and 1,25-DHCC and glucocorticoid, 
high alkaline phosphatase activity, synthesis of type I collagen matrix 
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and synthesis of the bone-associated proteins, e.g., osteocalcin 
(Hauschka et al, 1975; Price et al, 1976) and osteonectin (Termine et al, 
1981). 
A variety of in vivo techniques have been developed for the 
assay of osteogenic capacity of the osteoblast-like cells isolated, such as 
• .f • 
grafting the cell layers onto chorioallantoic membranes (Nijweide et al, 
1982) inoculation of isolated cells intramuscularly (Moskalewski et al, 
1983) and intraperitoneal implantation (Simmons et al, 1982). However, 
such techniques have not shown controllable investigations of the factors 
involved in osteogenesis and its regulation. In vitro culture of the 
osteoblast-like cells can override this problem. 
( 
38 
Introduction Aim & Scope 
• ‘ - i ' * 
1-6 AIM AND SCOPE OF THIS DISSERTATION 
Since elevated serum alkaline phosphatase has been observed 
in many diseases status, it is necessary to distinguish the sources of this 
elevated serum enzyme activity. Increased level of serum bone-specific 
alkaline phosphatase has long been referred to as having increased 
osteoblastic activities in bone which could be due to pubertal growth 
spurt of bone, in malignant diseases of bone and in bone fracture. In the 
present study, the levels of bone-specific alkaline phosphatase were 
measured to see whether it could act as a marker of bone diseases. 
The present study was divided into several parts. Bone 
fracture operations were carried out on the tibiae of rabbits. The plasma 
were weekly sampled and the bone-specific alkaline phosphatase 
measured to see whether it could act as a marker enzyme on monitoring 
the progress of fracture healing. The progress of fracture healing would 
also be monitored radiologically as a reference. Rabbits were killed at 
different time so as to obtain the callus for the extraction of alkaline 
phosphatase. 
The serum levels of bone-specific alkaline phosphatase were 
also measured in normal Chinese adults and in local patients with bone 
< 
fracture and osteosarcoma. The above studies were in collaboration with 
the Department of Orthopedics and Traumatology in the Prince of Wales 
Hospital of the Chinese University of Hong Kong. 
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Parallel studies of bone-specific alkaline phosphatase as an 
index of osteogenesis would be done on the in vitro culture of fetal rat 
calvarial osteoblast and UMR-106. ALP secreted into the medium 
would be assayed to monitor the profile of secretion. Cellular ALP, 
deposition of calcium phosphate and collagen synthesis would also be 
studied. 
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2.1 BONE FRACTURE OPERATION 
2.1.1 Animals 
Adult female rabbits (New Zealand White) were used, aged 
ranged from 30 weeks to 45 weeks. Body weights ranged from 4 to 6 
Kg. Animals were provided by the Animal House of the Chinese 
University of Hong Kong. 
2.1.2 Blood Sampling and Preparation of Plasma Samples 
Venepuncture was performed on the right ear of rabbits (Fig. 
2-1). The hair covering the vein was removed. The vein was then 
warmed and dilated with the application of xylene around the vein. 
Venepuncture was performed with 21G, 22G or 23G winged infusion set 
(JMS). Usually, 21G needle was preferred in order to reduce the risk of 
hemolysis. Approximately 6 mL 
/ I \ freshly sampled blood was 
/ I Vv immediately transferred to a 10-
Centeral "/ T| \ \
 Vein mL heparinized tube with beads 
[ J If for°vcne- coated with ammonium heparin 
\ l I puncture 
I I (SARSTEDT) and mixed the tube 
I J inversely for about 30 times. The 
J i f use of inversion mixer was 
I I recommended. The tube was then 
chilled to 0 C Plasma sample was 
Fig. 2-1 Right ear showing the main obtained by centrifugation at 
artery and vein. Arrows show the
 for 1Q m i n u t e s a n d s t o r e d 
direction of blood flow. 
at -70oC. 
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2.1.3 Bone Fracture Operation 
2.1.3.1 Reagents and Apparatus 
Anesthetic: sodium pentobarbital (2.5%, w/v) 
2.5 g sodium pentobarbital was dissolved in 100 mL 70% 
ethanol. 
Xylene for blood sampling 
Antiseptics: Hibitane concentrate and 1% diluted Hibitane 
Hibitane concentrate (chlorhexidine gluconate, 5%, w/v) was 
perchased from ICI Pharmaceuticals. 1% Hibitane was prepared by 
diluting 50 mL Hibitane concentrate to 5 L with 70% ethanol. 
Sterile syringe (5 mL, 10 mL) (TERUMO) 
Winged infusion set (21G, 22G or 23G) (JMS) 
Heparinized tubes (10-mL tubes) with beads coated with ammonium 
heparin (SARSTEDT) 
Surgical apparatus 
Scissors, scalpel, forcep, retractor, needle holder, periosteum 
elevator, hammer, drill, hacksaw and intramedullary nails (K-wires) 
were sterilized by Hibitane concentrate first and then 1% Hibitane. 
Covering clothes and bandages 
Covering clothes and bandages were sterilized by autoclaving 
at 121°C, 15 psi for 30 minutes and dried in 80°C oven overnight. 
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Sterile surgical blade (PARAGON) 
Dexon '5' polyglycolic acid suture, synthetic, absorbable, USP. 
Plaster of Paris 
2.1.3,2 Procedures 
The rabbit was anesthetized by intravenous injection of about 
3 mL sodium pentobarbital anesthetic into the left ear. In the rest of the 
operation, the syringe containing anesthetic was left inserted in the vein 
with the aid of an adhesive tape to fix the position of the winged infusion . 
needle. A blood sample was taken at zero week on the right ear. Bone 
fracture operation would be executed on the left tibia of the rabbit. 
The hair of the left leg was removed first and the leg was 
washed with diluted Hibitane. The rabbit was then transferred onto the 
. . . , • i • , 
autoclaved clothes. From now, the operation was performed following 
the standard aseptic technique for general surgical operations. The 
naked leg was sterilized again with concentrated Hibitane. Prior to the 
operation, made sure the rabbit was totally unconscious by further 
injection of minimum necessary amount of sodium pentobarbital. 
A longitudinal cut of about 2 cm was made on the mid-shaft of 
the leg (Photo 2-1)'. With the aid of a periosteum elevator and a 
retractor, the tibial shaft was exposed (Photo 2-2) and fractured 
transversely with a hacksaw (Photo 2-3 and Photo 2-4). Two K-wires 
were inserted into the bone marrow by a drill (Photo 2-5 to Photo 2-8). 
The wound was subsequently sutured by polyglycolic acid suture firstly 
on the periosteum (Photo 2-9) and then on the skin (Photo 2-10). The 
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fractured leg was fixed with plaster of Paris. Operational control was 
done by exposing the tibial shaft; without fracturing, the periosteum and 
wound were sutured immediately. The plaster of Paris was removed two 
weeks after the operation. Blood was sampled weekly or biweekly 
depending on experimental condition. Rabbits were killed at a certain 
time so as to obtain calluses healed at different stages. 
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2.1.4 Radiography 
Radiography was performed on both the fractured legs of alive 
rabbits and the tibiae removed from timed rabbits. For alive rabbit 
radiography, the rabbit was firstly anesthetized by intravenous injection 
of 2 mL sodium pentobarbital anesthetic. Radiography was taken at 45 
kV 1.5 mas for alive rabbit and at 42 kV, 1.5 mas for tibiae removed 
from rabbits after being killed at different time intervals using an X-ray 
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2.1.5 Removal of Tibiae 
Tibiae were removed from rabbits after being killed at various 
times for the extraction of callus bone-specific ALP. The rabbit was. 
anesthetized by injecting 5 mL sodium pentobarbital anesthetic 
intravenously. The final blood sample was taken from the heart. The 
animal was then sacrificed by intravenous injection of 10 mL saturated 
KC1 solution. The tibia was then removed with the aid of a scalpel and a 
bone cutter. Two intramedullary nails were also taken away. After the 
muscle residue and connective tissue around the callus had been cleared, 
the tibia was refrigerated at -70°C until further processing. 
2.1.6 Extraction of Callus ALP 
2.1.6.1 Reagent 
Borate Buffer (0.1 M, pH 7.03) 
I • “ 
6.183 g boric acid (H3B03: MW 61.83) was dissolved in j 
approximately 950 mL distilled water (pH 5.5). The acid was titrated 
to pH 7.03 with 0.2 N NaOH at 18 C - 20°C. The solution was diluted 
to 1 L with distilled water. 
2.1.6.2 Homogfiiiizatio" nf the Callus 
The tibiae freezed at -70°C were brought to room temperature 
and the shaft was washed with ice-colded 0.1 M sodium borate buffer j 
(pH 7.03). The portion of callus chosen for ALP extraction was 5 mm | 
apart from the middle line of the callus extended to both directions (Fig. | 
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 together with the compact bone of 
^ ^ the fracture site by an electric saw 
and crushed into small pieces with 
C
K
 L > the bone cutter. The small callus 
5mmpmm 
pieces were homogenized with 
Fig. 2-2 Diagram showing the portion nitrogen in a stainless steel j 
of callus chosen for ALP extraction homogenizer cooled at -70°C 
(shaded area). . , , , « , • ‘• 
overnight before homogenization. I 
The homogenates were divided 
into two to three portions and transferred to 1.5-mL Eppendorf tubes. 
The wet weights of the samples were recorded. Then the Eppendorf 
tubes were covered with parafilm on which a small hole was pinned with 
a needle. The samples were subjected to lyophilization for 24 hours by 
I ^^ H^ I 
lyophilizor LABCONCO. After lyophilization, the dry weights of the 
I : 
samples were recorded. These samples were either stored at -70°C or 
I 
subjected to ALP extraction immediately. 
I 
2A.63 EYtrartinn of ALP 
The samples were transferred to pre-weighed 12 mm x 75 mm j 
opaque plastic tubes and the dry weights of the sample transferred were 
recorded. To the callus samples, 2 mL 0.1 M sodium borate buffer (pH 
7.03) were added and the ALP was extracted with constant mixing by 
inversion mixer for 24 hours at 4°C. The mixture was then centrifuged | 
at 3 500xg for 20 minutes at 4°C (Beckman AccuSpin FR). One 
hundred folds aqueous solution of the supernatants were prepared and 
the diluted supernatants were taken for routine ALP assays. 
I) • •- . . . . . . . , 
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2.1.7 Assay for Bone-Specific ALP 
The method described by Rosalki and Foo (1984) was adopted 
for the assay of bone-specific ALP. The original method required two-
step incubation with a pre-treatment of Triton X-100 provided that 
serum sample demonstrated the presence of biliary ALP. The pre-
incubation was time-consuming and would complicate the calculation of 
bone-specific ALP activity. The original authors subsequently modified 
their method so that only one step incubation would be necessary for the 
precipitation of bone-specific ALP (Rosalki and Foo, 1986). The 
modified method was adopted in the assessment of bone-specific ALP in 
the plasma samples and callus extracts. 
2.1.7.1 Reagents 
• 
Wheat Germ Lectin / Triton X-100 Mixture 
Lectin of wheat germ from Triticum vulgaris was purchased 
from SIGMA and Triton X-100 from Scintran BDH. A solution 
containing 5 g/L lectin and 40 g/L Triton X-100 was prepared by | 
dissolving 0.0275 g lectin and 0.22 g Triton X-100 in 5.5 mL distilled 
water. Complete dissolution was achieved by vortexing the solution for 
at least 30 minutes. 
• 
» 
p-Nitrophenylphosphate Substrate Solution for Autoanalysor (AMP j 
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2.1.7,2 Procedures 
The plasma samples and callus extracts stored at -70°C were 
thawed and kept at room temperature. Precipitation of bone-specific 
ALP was achieved by mixing 50 jih plasma samples or diluted callus 
extracts with equal volume of wheat germ lectin/Triton X-100 solution. 
The mixtures were incubated at 37°C shaking water bath for 30 minutes. 
After incubation, the mixtures were centrifuged at 2 000xg for 10 




Routine alkaline phosphatase kinetic assays were assessed by 
the hydrolysis of p-nitrophenylphosphate at alkaline medium performed 
by COBAS BIO autoanalysor (ROCHE Diagnostica). The liberated p-
nitrophenylate shows maximum absorption at 405 nm (Fig. 2-3). The 
rate of the increase in yellow color is directly proportional to the alkaline 
phosphatase activity in the sample. 
N02 NO2 
r A A L P 3- 1 
I + H2O > || + P04 
Alkaline ^ ^ 
O O" 
0 : - 0 pnitrophcnylatc O" (yellow) 
t 
pnltrophenyl maximum 
phosphate absorption at 
405 nm 
Fig. 2-3 Hydrolysis of the artificial substrate for ALP, p-
nitrophenylphosphate. The reaction was processed at alkaline 
medium. The product, p-nitrophenylate ion shows maximum 
absorption at 405 nm. 
'. I 
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50 fiL samples (plasma, diluted callus extracts, or supernatants 
separated from the precipitations of bone-specific ALP obtained after 
lectin reaction of plasma or diluted callus extracts) were pipetted to the 
tubes for COBAS BIO autoanalysor. The reagent chamber was filled 
with p-nitrophenylphosphate substrate solution. The cuvette ring was 
installed into the autoanalysor and the machine was set to 'SINGLE 
RUN' as well as the following parameters: 
1. UNITS U/L 
2. CALCULATION FACTOR 2258 
3. STANDARD 1 CONC 0 
4. STANDARD 2 CONC 0 
5. STANDARD 3 CONC 0 
6. LIMIT 0 
7. TEMPERATURE [DEG.C] 37.0 
8. TYPE OF ANALYSIS 2 
9. WAVELENGTH [NM] 405 
10. SAMPLE VOLUME [UL] 06 
11. DILUENT VOLUME [UL] 50 
12. REAGENT VOLUME [UL] 250 
13. INCUBATION TIME [SEC] 0 
14. START REAGENT VOLUME [UL] 0 
15. TIME OF FIRST READING [SEC] 110.0 
16. TIME INTERVAL [SEC] 10 
17. NUMBER OF READINGS 15 \ 
18. BLANKING MODE 1 
19. PRINTOUT MODE 1 
I 
.. ^^ H I 
For each sample, pair assays were performed, one for the total 
I .. f • v . ' || 
ALP in plasma or diluted callus extract, and the other for the non-bone 
ALP in the supernatant of the plasma or diluted callus extract after lectin j 
reaction, respectively. Bone-specific ALP activity was calculated from | 
the difference between the two values, as shown below: 
Bone-specific ALP (U/L)=Total ALP (U/L) - 2 x Non-bone ALP (U/L) 
I . . . . . . … . . . . ‘ •' . . . . . . . ’ : , I 
. . I 
f . . • 
I , : . ‘ . , . . . . . . . . . . . . , : • / , 
% 
. . . . 
. : . • • I 
I'm- . - - . - . . . I 
55 • ’ ’ | , . ’ 
Materials & Methods Bone Fracture Operation 
Control sera from human (Total ALP activity = 150.74 4.08 U/L) and 
rabbit (Total ALP activity = 140.51 2.40 U/L) were included in each 
run of 22 assays. 
• . 
I 2.1.8 Normal Curve for Plasma Bone-Specific ALP in Rabbits 
# 
Normal levels of plasma bone-specific ALP were determined 
I from rabbits in a group of 4. Blood were sampled weekly from the age 
of 30 weeks to 64 weeks and the plasma samples were subjected to 
routine assays for bone-specific ALP activity. 
2.1.9 The Effects of Tibial Fracture on the Plasma Level of 
I Bone-Specific ALP in Rabbits 
1 i 
Twelve rabbits were divided into two groups. The ages of the 
rabbits in these two groups were between 30 and 35 weeks. The rabbits 
j in the experimental group were taken for the surgery of tibial fracture. 
Those rabbits in the operational control group underwent cutting of skin 
and periosteum without fracturing as described in Section 2.1.3.2. Blood 
I samples were taken weekly for the first two weeks and biweekly for the 
j subsequent 6 weeks and the animals were sacrificed and tibiae removed 
at 8 weeks. , 
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2.1.10 Profile of Plasma Bone-Specific ALP upon a Fracture 
Healing 
Twenty three rabbits were taken for the surgery of tibial 
fracture. Twelve of them were operated at 36 weeks (the premature 
group) and the rest eleven at 45 weeks (the mature group). Because of 
the limitation of animal supply, no operational controls were done in this 
experiment. Blood were sampled weekly. Rabbits were killed and tibiae 
removed in a scheme according to Table 2-1. One rabbit being 
terminated at week 16 was subjected to alive rabbit radiography on the 
fractured leg biweekly. Tibia removed from each rabbit was also 
subjected to radiography. 
Table 2-1 Scheme of rabbit sacrifice. 
I Post-fracture I No. of Rabbits Killed I 
(Weeks) 
• 
2.1.11 Profile of Callus Bone-Specific ALP at Different Stages 
of Fracture Healing 
Callus obtained from the twenty three rabbits were processed 
according to Section 2.1.6 and the diluted callus extracts were taken for 
routine bone-specific ALP assessment (Section 2.1.7). 
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2.2 CLINICAL STUDIES OF PLASMA BONE-SPECIFIC ALP 
The plasma levels of bone-specific ALP would be determined 
in normal adults, patients with long bone fracture and with 
osteosarcoma. These studies were in collaboration with researchers of 
the Department of Orthopedics and Traumatology, the Chinese 
University of Hong Kong. 
2.2.1 Patient Groups 
2.2.1.1 Normal Adults 
85 normal Chinese adults (age 20-60) including 49 males and 
36 females were studied. These normal adults have no past history, 
signs and symptoms of existing bone and liver diseases. 
2.2.1.2 Fracture Group 
The plasma levels of bone-specific ALP from the fracture 
group were determined from 49 patients with closed fracture of single 
long bone. The patients were treated with either closed reduction with 
external immobilization with plasters or braces or closed intramedullary 
nailing. The fracture hematoma was not disturbed in all these patients. 
Serial blood samples were taken at 2 4, 8 12’ 16 24 and 30 weeks after 
the fracture. 
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2.2.1.3 Tumor Group 
Plasma bone-specific ALP activities were determined in 15 
patients with osteosarcoma. 
2.2.2 Assays for Plasma Bone-Specific ALP 
The precipitation of the bone-specific ALP from the plasma 
samples by wheat germ lectin and the assay method were exactly the 
same as those for the rabbit plasma samples as described in Section 
2.1.7. 
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2.3 IN VITRO CULTURES OF FETAL RAT OSTEOBLASTS 
AND UMR-106 OSTEOSARCOMA CELL LINE 
2.3.1 Animals 
Timed pregnant Sprague-Dawley rats at 20 days of gestation 
were used. Three rats bearing approximately 45 fetuses totally were 
sacrificed for each time of osteoblast isolation procedure. Animals were 
provided by the Animal House of the Chinese University of Hong Kong. 
2.3.2 UMR-106 Cell Line 
Rat UMR-106 osteosarcoma cell line was purchased from the 
American Type Culture Collection (ATCC, Catalog no.: CRL1661). 
2.3.3 General Reagents Used for Cell Culture 
Phosphate Buffered Saline (PBS) and Half Saline 
The reagent composition is listed in the Appendix. PBS was 
prepared by dissolving the appropriate amount of chemicals in 95% final 
volume of doubled distilled water. The solution was titrated with 1 M 
NaOH or 1 M HC1 to pH 7.4 at room temperature and diluted to the final 
volume required with doubled distilled water. Half saline was prepared 
by dissolving half of the amount of chemicals required to prepare PBS in 
50% final volume of doubled distilled water. The solution was titrated 
with 1 M NaOH or 1 M HC1 to pH 7.4 at room temperature and diluted 
to 100% final volume. PBS and half saline were sterilized by 
autoclaving at 121°C, 15 psi for 30 minutes. 
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Hank's Balanced Salt Solution (HBSS) 
Reagent formula for HBSS is listed in the Appendix. HBSS 
was prepared by dissolving appropriate amount of chemicals in 95% 
final volume of doubled distilled water. The solution was titrated by 1 
M NaOH or 1 M HC1 to pH 7.2 at room temperature and diluted to 
100% final volume with doubled distilled water. The solution was 
filtered through a sterile 0.45 Jim membrane filter (Millipore) by 
negative pressure (air suction). A sample of the sterile HBSS was taken 
for pH measurement. Usually, the pH would be around 7.4 0.05. 
Hank's Balanced Salt Solution Devoid of Calcium and Magnesium 
(HBSS without Ca2+ and Mg2^) 
Preparation of HBSS without Ca2+ and Mg2+ was the same as 
that of HBSS except that CaCl2.2H20, MgCl2.6H20 and MgS04.7H20 
were deleted from the formula. 
Dulbecco's Modified Eagle's Medium (DMEM) 
Dulbecco's Modified Eagle's Medium powder was purchased 
from SIGMA Chemicals Company (Catalog no.: D1152). The powder 
required to prepare 1 L medium was dissolved in 950 mL doubled 
distilled water. The original package was rinsed with doubled distilled 
water to remove the residual powder and added to the medium. 3.700 g 
sodium bicarbonate (NaHC03) was added to the medium which was then 
titmted with 1 M NaOH to pH 7.2 at room temperature. The medium 
was diluted to 1 L with doubled distilled water and immediately 
sterilized by filtration through a sterile 0.45 membrane filter 
(Millipore) by negative pressure (air suction). Sample of sterile medium 
was taken for the pH examination (pH 7.4 ± 0.05). Sterility of the 
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medium was checked by incubating the medium at 37°C overnight. The 
medium was stored at 4°C after incubation. 
Minimum Essential Medium (Alpha Modification) (aMEM) 
The alpha modification of Eagle's Minimum Essential Medium 
m 
(aMEM) was purchased from SIGMA Chemicals Company (Catalog 
I I • 
j no.: M0894). The formula contains L-glutamine and does not contain 
ribonucleosides, deoxyribonucleosides or sodium bicarbonate. The 
I 
preparation of aMEM was similar to that of DMEM except that 2.200 
I ' 
g/L sodium bicarbonate was added instead. 
I 
I RPMI-1640 Medium 
i Large scale preparation of RPMI-1640 medium (SIGMA 
Chemicals Company, Catalog no.: R4130) was done for 20 L. 
j Preparation was similar to DMEM and aMEM but 2.0 g/L sodium 
I ‘ 
bicarbonate was added (total 40 g added to 20 L preparation). pH 
9 
adjustment was impossible in this large scale preparation. The medium 
was immediately sterilized by filtration using membrane filter with the 
porosity of 0.2 pim (Millipore) by positive pressure (compressed nitrogen 
gas). The sterile medium was aseptically dispensed into sterile bottles 
j and the sterility of the medium was checked by incubating the medium 
at 37°C overnight. After incubation, the medium was stored at 4°C. 
I 
$ 
' * ' 
Fetal Bovine Serum (FBS) 
J Fetal bovine serum (FBS) was purchased from GIBCO 
I Chemicals Company (Catalog no.: 200-6140AJ). 50 mL aliquots were 
prepared aseptically and stored at -20°C. 
I 
• 
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I 
I Trypsin / EDTA Solution 
3 
Trypsin I EDTA solution was purchased from GIB CO 
Chemicals Company (Catalog no.: 610-5300AJ). The solution contains 
0.05% trypsin and 0.53 mM EDTA (ethylenediamine tetraacetic acid, 
I . 





Mixture of penicillin G sodium salt (10,000 U/mL) and 
streptomycin (10,000 /^g/rnL) was obtained in lyophilized powder for 20 
j mL preparation (GIBCO, Catalog no.: 600-5145AE). Antibiotics 
powder was resuspended in 20 mL sterile double distilled water. The 
' 






Standard medium referred to the medium supplemented with 
fetal bovine serum and antibiotics. 10% FBS containing standard 
I medium was prepared by mixing 450 mL plain medium (medium 
1 without any supplements), 50 mL FBS and 5 mL rehydrated antibiotics 
(penicillin G and streptomycin). 15% FBS containing standard medium 
I was prepared by mixing 425 mL plain medium with 75 mL FBS and 5 
J
 m L rehydrated antibiotics (final concentration: penicillin G, 100 U/mL; 
streptomycin, 100 pg/mL). • 
Supplemented Medium 
I Supplemented medium referred to the standard medium 
I supplemented with 50 pg/mL L-ascorbic acid and 10 mM sodium 
J glycerophosphate. 50 mg L-ascorbic acid (Riedel-de Haen) was 
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dissolved in 2 mL double distilled water. The solution was filtered 
through a sterile 0.45 pim membrane filter (Millipore). 9.0 g sodium (3-
glycerophosphate tetrahydrate (SIGMA) and 0.225 g sodium chloride 
were dissolved in 25 mL doubled distilled water (the final volume will 
I . 
expand to 30 mL). The solution was filtered through a sterile 0.45 Jim 
membrane filter. For each 500 mL standard medium, 1 mL freshly 
prepared ascorbic acid and 4.8 mL sodium P-glycerophosphate solution 
1 were added. Since the original formula for aMEM contains 50 mg/L L-
ascorbic acid, only 4.8 mL sodium (3-glycerophosphate solution were 
1 , 
added to each 500 mL standard medium when aMEM supplemented 
I . . 
medium was prepared. 
I 9 • 
I : 
1 2.3.4 Isolation of Calvarial Osteoblasts 




- . . 
Dissection tools including scissors, scalpels, forceps, surgical 
Pi • 
I blades and necessary glasswares were sterilized by autocalving at 121 C, 
I 15 psi for 30 minutes and dried for 30 minutes. 
I 
• • I I I I I 
Dissection Balanced Salt Solution (DBSS) 
I Dissection balanced salt soultion was . Hank's balanced salt 
I solution (HBSS, see Appendix) without sodium bicarbonate 
I supplemented with 200 U/mL penicillin G, 200 ^g/mL streptomycin, 50 
I ^g/mL gentamycin and 2.5 ^g/mL amphotericin B. 1.25 mg 
I amphotericin B (SIGMA, Catalog no.: A2411) was dissolved in 
I approximately 400 mL doubled distilled water and the solution brought 
64 ‘ 
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. . - . a ‘ . 
to pH « 1 1 with NaOH first since the solubility of amphotericin B at pH 
I 
7 is very low. After the amphotericin B had been thoroughly dissolved, 
‘ 
the chemicals required to prepare 0.5 L HBSS were added except sodium 
_ 
bicarbonate. Subsequently, 10 mL antibiotics (penicillin G and 
B .-
streptomycin) and 0.5 mL gentamycin solution (50 mg/mL gentamycin 
I ' 
sulfate, GIBCO, Catalog, no. 600-5750AD) were added to the solution. 
The solution was titrated with 1 M HC1 to pH 7.2 at room temperature 
I 
and diluted to 500 mL with doubled distilled water. The solution was 
immediately sterilized by membrane filtration (0.45 }imy Millipore) with 
I. . • 
negative pressure (air suction). 
Collagenase Solution (3 mg/mL) 
I Crude collagenase (Type IA, SIGMA, Catalog no.: C9891) 
was dissolved in a balanced salt solution (see Appendix) at the 
I concentration of 3 mg/mL. The collagenase solution was stirred at room 
temperature for 2 hours, sterilized by membrane filtration (0.45 Jim 
j Millipore) with positive pressure and stored frozen at -20°C in 33 mL 
I • 
aliquot. 
Hank's Balanced Salt Solution 
Phosphate Buffered Saline and Half Saline 
I 15% FBS containing RPMI-1640 Standard Medium 
15% FBS containing oMEM Standard Medium 
D A Procedures 
I The method decribed by Bellows et al (1986) was adopted for 
I
 t h e isolation of fetal mt calvarial osteoblast-like cells with slight 
" . 
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Fig. 2-4 Diagram of the fetal rat skull. Fig. 2-5 Tracing of the excised 
Dashed line indicates that portion of the fetal rat calvarium. Areas inside 
calvarium routinely taken for study. dashed lines are the portions of 
the frontal and parietal bones 
modifications. Timed pregnant rats removed for osteoblast isolation. 
Areas of primary and secondary 
at 20 days of gestation were killed by
 jn t h e 2 0 .day fetus 
cervical dislocation. The abdomen
 a r e indicated by white bars and 
I was opened with sterile instruments strippling respectively. 
after sterilization of the fur by 70% 
alcohol. Both horns of the uteri were excised and transferred quickly to 
DBSS. The uteri were placed into the tissue culture hood immediately. 
Subsequent steps of the isolation procedure were done aseptically. 
B. • I 1 
1 The fetuses were removed, rinsed in half saline and PBS 
j sequentially for a few seconds and transferred to HBSS immediately, 
j The fetus was held'in an upright position by a forcep. The calvarium 
j was dissected out (Fig. 2-4) and rinsed with half saline and PBS in 
sequence for a few seconds. The calvarium was immediately transferred 
I
 t o 15% FBS containing RPMI-1640 standard medium. Under a 
I dissection microscope (OLYMPUS, Model: SZ-ET), the frontal and 
j parietal bones were dissected out (Fig. 2-5). The periosteum on the 
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dorsal surface was stripped away and the bones were transferred to 15% 
FBS containing RPMI-1640 standard medium. The dissected calvaria 
I . 
were minced finely and transferred to a sterile plastic capped culture 
1 
tube (FALCON). The minced calvaria pieces were centrifuged down 
and washed once or twice with HBSS. 
The calvaria were then digested with 7 mL collagenase 
solution (3 mg/mL) at 37°C for 10 minutes with magnetic stirring. At 10 
minutes, the collagenase solution together with the released cells were 
aspirated after the large pieces of calvaria had been sedimented, and 
mixed with 23 mL 15% FBS containing RPMI-1640 standard medium. 
Another 6 mL fresh collagenase solution were added. Digestion 
procedure was repeated at 20 min. 30 min. 50 min. and 70 min. The 
cells released at the five stages were all mixed to the same pool. The 
I released cells were then centrifuged at l 800xg at 4 C for 5 minutes and 
I washed twice with HBSS. The cells were then cultured with 15% FBS 
containing ocMEM standard medium in 75 cm2 disposable culture flask 
(CORNING, Catalog no.: 25115-75) at 37 C incubator (5%C02 I 95% 
J air) overnight. The adherent monolayer was washed twice with HBSS in 
I order to get rid of any non-adherent cells, such as erythrocytes. The 
adherent cells were cultured with 15% FBS containing aMEM standard 
I 
medium for 3 to 4 days until confluent. 
p 
_ 
j 2.3.5 Storage of UMR-106 Cell Line 
• ^H I I I 
a Upon receiving from the supplier, the UMR-106 cell line was 
i thawed at 37 C within 1 minute. The cells were aseptically transferred 
to 10 mL 10% FBS containing DMEM standard medium and centrifuged 
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immediately at l 300xg for 5 minutes. The cell pellet was washed with 
‘ 
I • 
HBSS three times. Finally, the cell pellet was resuspended in 10% FBS 
. 
containing DMEM standard medium and incubated at 37°C (5%C02 / 
95% air) overnight. The adherent cells was subcultured when confluent. 
Part of the cells was taken for cell line maintenance. Cell line was kept 
at the concentration of 1 x 107 cells / mL in 4% DMSO 
(dimethylsulfoxide) / 96% FBS. The cell suspension was frozen at 
-20°C overnight and then in liquid nitrogen. 
I 
2.3.6 Subculture of Confluent Monolayer 
2.3.6.1 Reagents 
Trypan Blue Dye (0.4%) 
Trypan blue dye for viable cell number assessment was 
prepared by dissolving 0.2 g trypan blue crystal (SIGMA, Catalog no.: 
j T0776), 0.384 g NaCl, 0.0256 g KC1 and 0.0615 g Na2HP04- 12H20 in 
50 mL distilled water. 
I Trypsin / EDTA 
HBSS 
I HBSS without Ca2+ and Mg2+ 
J Standard Medium, 10% FBS containing DMEM for UMR-106 Cell 
Line; 15% FBS containing aMEM for Fetal Rat Calvarial 
g : ‘ 
I Osteoblasts. 
I ' , v ~ V . . . . . . ‘ 
I • 
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Confluent monolayer of cells, UMR-106 or calvarial 
j osteoblasts, was rinsed twice with HBSS without Ca2+ and Mg2+. 
‘ 
Trypsin / EDTA solution was added to the monolayer (1 mL for 75 cm2 
1 
and 0.5 mL for 25 cm2 culture flask) and the culture flask incubated at 
37°C for 3 to 5 minutes. Several milliliters of FBS containing medium 
were added to stop the trypsinization. Generally, 15% FBS containing 
aMEM was used for the culture of calvarial osteoblasts and 10% FBS 
containing DMEM for UMR-106 cells. The cells were dispersed by 
repetitive pipetting against the monolayer. The released cells were 
aspirated out. The flask was rinsed with the corresponding standard 
medium and the medium pooled to the released cells. The cells were 
centrifuged at 1500xg for 10 minutes. The cell pellet was washed with 
• 
HBSS twice and finally resuspended in standard medium or plain 
‘ 
medium depending on the experiments. Viable cell number was counted 
under hemocytometer by trypan blue exclusion test. UMR-106 cell line 
was maintained by seeding 1 x 106 cells to 75 cm2 Corning culture flask 
I 
and cultured with 10% FBS containing DMEM standard medium at 
I 
I 37°C (5%C02 / 95% air), 
j 2.3.7 Staining for Calcium Deposits 
I 
* 
I Von Kossa technique (Pearse, 1968) with slight modifications 
I was employed for the staining of calcium deposits. 
I 
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2.3.7.1 Reagents 
Neutral Buffered Formalin (NBF) 
Formula for NBF is shown in the Appendix. Components 
were dissolved in distilled water to about 450 mL. The solution was 
adjusted to pH 7.0 with 1 M NaOH or 1 M HC1 at room temperature. 
The solution was diluted to 500 mL with distilled water. 
Silver Nitrate Solution (1.5%) 
1.5 g silver nitrate (AgN03) was dissolved in 100 mL distilled 
water. The solution is light sensitive and kept in dark environment at 
room temperature. 
Sodium Thiosulfate (5%) 
7.85 g sodium thiosulfate pentahydrate (Na2S203.5H20) were 
dissolved in 100 mL distilled water. 
U 7 - 2 Procedures 
The monolayer of culture was fixed with NBF overnight (1 
mL for 6-well plate, 10 mL for 75 cm2 culture flasks, Corning). The 
fixed tissue was rinsed with distilled water. The tissue was then exposed 
to direct sunlight or electric light bulb in the presence of silver nitrate for 
30 minutes. After exposure, the tissue was rinsed well with distilled 
water. The silver ion was reduced by sodium thiosulfate solution for 1 
minute. The stained tissue was rinsed well with distilled water. 
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2.3.8 Protein Determination 
Method described by Bradford was employed for the 
determination of protein content (Freshney, 1987). 
2.3.8.1 Reagents 
Coomassie Brilliant Blue (0.01% w/v) 
100 mg Coomassie Brilliant Blue G250 (SIGMA, Catalog no.: 
B1131) were dissolved in 50 mL 95% ethanol. The above solution was 
mixed with 100 mL 85% phosphoric acid and diluted to 1 L with 
distilled water. 
Bovine Serum Albumin (BSA) Standard 
Bovine serum albumin (SIGMA, Catalog no.: A9647) was 
prepared at stock concentration of 1 mg/mL. BSA standards were 
prepared at 0 25’ 50 75 and 100 g/mL in 0.3 N NaOH as diluent. 
NaOH Solution (0.3 N) 
Procedures 
Proteins or cells were solubilized in 0.3 N NaOH and heated in 
boiling water bath for several minutes. 100 yL diluted proteins were 
mixed with 2 mL Coomassie Blue solution and let stand for 10 minutes 
at room temperature. Absorbance was read at 595 nm with the BSA 
standards by HITACHI U-2000 spectrophotometer. 
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2.3.9 Microdetermination of Inorganic Phosphate 
Ascorbic acid method to determine inorganic phosphate 
described by Chen et al (1956) was employed. 
2.3.9.1 Reagents 
Sulfuric Acid (6N) 
15.99 mL concentrated sulfuric acid (95-97%, Riedel-de Haen, 
Catalog no.: 30743) were diluted to 100 mL with distilled water. 
Ammonium Molybdate (2.5% w/v) 
2.5 g ammonium molybdate powder were dissolved in 100 mL 
distilled water. 
Ascorbic Acid (10% w/v) 
Ascorbic acid was prepared freshly in each time of assay. 0.1 
g/mL L-ascorbic acid was dissolved in distilled water. 
Phosphate Standard 
Phosphate stock solution was prepared by dissolving 0.0136 g 
KH2P04 (MERCK) in 100 mL distilled water (ImM KH2P04). 
Phosphate standards1 were prepared at the concentration of 0 25 50 75 
and 100 ]iM in 0.5 M HC1 as diluent. 
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2.3.9,2 Procedures 
Reagent C was prepared freshly by mixing sulfuric acid, 
ammonium molybdate, ascorbic acid and water in volume ratio 1:1:1:2. 
1 mL phosphate standards or samples was mixed with 1 mL reagent C. 
The mixture was incubated at 37°C for at least 90 minutes. Absorbance 
were read at 820 nm by HITACHI U-2000 spectrophotometer. 
2.3.10 Determination of Calcium 




Concentrated calcium stock (lOOOx) was prepared by 
dissolving 2.497 g dried calcium carbonate (CaC03) in minimum 
volume of 20% (v/v) nitric acid. The solution was diluted with distilled 
water to 1 L (1000 "g/mL calcium). Calcium standards were prepared at 
1 2 3 4 and 5 jig/mL in KC1 solution so that each solution contained 
5000 pg/mL K+ for the suppression of ionization of calcium atom. 
2.3.10.2 Prnredures 
200 pcL sample was diluted in 1.8 mL KC1 solution (10.59 
mg/mL BDH) so that 5000 jig/mL K+ were included in each sample. 
Calcium levels were measured by Varian SpectrAA-10 atomic 
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absorption spectrometer using acetylene as fuel and nitrous oxide as 
support. The machine was set with the following parameters: 
Program No: 9 
Element No: 9 
Instrument Mode: ABSORBANCE 
Calibration: CONCENTRATION 
Measurement Mode: INTEGRATION 
Lamp Current: 4 mA 
Sample Introduction: MANUAL 
Delay Time: 2 sec 
Measurement Time: 2.0 sec 
Replicates: ‘ 1 
Background Correction: ON 
Wavelength was set to 422.7 nm and spectral band pass, 0.5 
nm. Distilled water was aspirated between introductions of samples. 
2.3.11 Extraction and Assay for Ceilular ALP 
H 1 1 - 1 Reagents 
ALP Extraction Buffer (pH 7.0) 
Formula for ALP extraction buffer is listed in the Appendix. 
Solution was prepared in distilled water and titrated with 1 M HC1 to pH 
7.0 at room temperature. 
ALP Diagnostic Kit 
Diagnostic kit for ALP was purchased from SIGMA (Catalog 
no.: 245-20). Powder in reagent bottle was reconstituted with 20 mL 
distilled water and let stand for at least 20 minutes. Occasional swirling 
might assist complete dissolution. 
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PBS 
2.3.11,2 Procedures 
Medium in monolayer culture was aspirated in 6-well plate 
and washed twice with PBS (sterile PBS was not necessary). 1 mL ALP 
extraction buffer was added and the tissue agitated at room temperature 
for 5 minutes by Titertek vortex mixer. If necessary, the cell layer was 
scrapped with a rubber policeman or plastic cell scraper. The tissue was 
homogenized by repetitive pipetting. The homogenate was aspirated, the 
well washed with 1 mL ALP extraction buffer and the buffer pooled to 
the homogenate. The homogenate was sonicated for 10 seconds in ice-
bath and stored frozen at -20°C. 
Precipitation of bone-specific ALP by wheat germ lectin was 
the same as that for plasma bone-specific ALP as described in Section 
2.1.7. Assessments of ALP was performed mannually with the 
diagnostic kit for ALP by HITACHI U-2000 spectrophotometer. 
Dilution of cell homogenates with ALP extraction buffer might be 
necessary when total ALP levels were assayed. 




^-Nitrophenylphosphate Substrate Solution (PNPP, 1% w/v) 
0.1 g p-nitrophenylphosphate disodium salt and 6.057 g Tris 
(Tris-hydroxymethyl-aminomethane, Riedel-de Haen) were dissolved in 
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90 mL HBSS. The solution was titrated with 1 M HC1 to pH 9.4 at room 
temperature and diluted to 100 mL with HBSS. 
PBS 
NaOH (1 M) 
2,3.12.2 Procedures 
The medium of monolayer culture was aspirated and the tissue 
was washed with PBS twice. 1 mL PNPP reagent was added to the well 
(of 6-well plate) and the tissue agitated gently at room temperature for 1 
minute (UMR-106 cells) or 5 minutes (normal calvarial cells). Reaction 
was stopped by aspirating the reagent and mixed well with 1 mL 1 M 
NaOH. Absorbance was read at 405 nm against a reagent blank (1 mL 
PNPP reagent mixed with 1 mL 1 M NaOH). Molar extinction 
coefficient of p-nitrophenol at pH 13 is 17,600 M^cm1 . 
2 3-13 Extraction of Calcium Phosphate Deposits 
H I Reagent 
HCl (0.5 N) 
I 
2 . 3 . 1 P r o c e d u r e s 
Monolayer of cells, after being assayed for cell surface ALP, 
was rinsed twice with distilled water. The calcium phosphate deposits 
76 ' ' 
Materials & Methods In Vitro Cultures 
/ , 
were dissolved by 1 mL ice-cold 0.5 N HC1. The well was rinsed with 
another 1 mL 0.5 N HC1 and the solution were pooled together. 
2.3.14 Collagen Synthesis Assay 
Rates of collagen synthesis were estimated by the collagenase-
digestion method described by Peterkofsky and Diegelmann (1971). 
2.3,14.1 Reagents 
3H-Proline in Medium 
0.055 g L-ascorbic acid and 0.055 g |3 -aminopropionitrile 
monofumarate (ALDRICH Chemical Co., Catalog no.: A7, 642-7) were 
dissolved in 1 mL distilled water. The solution was filtered by 0.45 pm 
membrane filter (Millipore) and 0.5 mL was added to 50 mL DMEM 
plain medium. 55 jiL PH]-proline stock (L-[2 3-3H] proline, 28 
Ci/mmol, 1.0 mCi/mL, AMERSHAM, Code no.: TRK 638) were mixed 
with 2.5 mL ascorbic acid and p-aminopropionitrile supplemented 
medium. 
PBS 
NaOH (0.1 N) 
HCl (0.09 N) 
10% TCA/0.5% Tannic Acid 
10 g trichloroacetic acid (TCA, FLUKA) and 0.5 g tannic acid. 
d 
(Riedel-de Haen) were dissolved in 100 mL distilled water. 
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5% TCA/0.25% Tannic Acid 
10% TCA/0.5% tannic acid was diluted with equal volume of 
distilled water. 
Collagenase Buffer 
Collagenase buffer contained 0.5 M Tris-HCl, 1 M CaCl2 and 
25 mM N-ethylmaleimide. 6.057 g Tris, 14.702 g CaCl2-2H20 and 0.313 
g N-ethylmaleimide(SIGMA, Catalog no.: E3876) were dissolved in 90 
mL distilled water. The solution was titrated with 12 N HC1 to pH 7.4 at 
room temperature and diluted to 100 mL with distilled water. 
High Purity Collagenase 
HPLC purified collagenase was purchased from SIGMA (Type 
VII Catalog no.: C0733). Collagenase solution was prepared at 500 
U/mL in double distilled water. 
Scintillant 
Formula for scintillation cocktail is listed in the Appendix. 
Overnight stirring was necessary for complete dissolution. The 




Monolayer of culture in 2 mL DMEM standard medium was 
pulsed with 200 pcU 4.4 piCl [3H]-proline (final concentration: [3H]-
proline 2 Ci/mL; ascorbic acid, 50 ^g/mL; p-aminopropionitrile, 50 
yg/mL). The plates were incubated at 37°C (5%C02 I 95% air) for 3 
hours or 4 hours depending on the experiments. At the end of the 
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incubation, the medium was removed and the well rinsed with PBS 
twice. The monolayer was dissolved in 1 mL 0.1 N NaOH and 
homogenized by Pasteur pipet. The homogenate was transferred to 2 
mL ice-cold 10% TCA/0.5% tannic acid. The well was rinsed with 
another 1 mL 0.1 N NaOH and the solution pooled to the 10% 
TCA/0.5% tannic acid. The mixture was left at 0°C for 5 minutes. The 
precipitated proteins were centrifuged at 29 000xg for 10 minutes 
(BECKMAN Model J2-21 Centrifuge). The supernatant was discarded 
and the pellet washed with 5% TCA/0.25% tannic acid and centrifuged 
again. The pellet was dissolved in 1 mL 0.1 N NaOH by warming at 
37°C water bath. After complete dissolution, the proteins were chilled to 
0°C. 0.2 mL solubilized proteins was partially neutralized by 0.2 mL 
0.09 N HC1. 50 piL collagenase buffer were added together with 50 jiL 
collagenase or 50 piL water as collagenase-free control (final reaction 
volume = 0.5 mL). The solution was mixed well and incubated at 37°C 
shaking water bath for 3 hours. Duplicates were done for each reaction. 
Collagenase digestion was stopped by adding 0.5 mL ice-cold 10% 
TCA/0.5% tannic acid and left in the ice bath for 5 minutes. The 
undigestible, precipitated proteins were centrifuged at 9’000xg for 10 
minutes (Heraeus Biofuge B). 0.5 mL supernatant was taken for liquid 
scintillation counting with 4 mL scintillant by BECKMAN LS1801 
scintillation counter. Amount of collagen synthesized was calculated by 
the difference between the c.p.m. released in the presence and the 
absence of collagenase. 
79 ' ' 
Chapter 3 
Effects of Tibial Fracture 
on the Level of Bone-
Specific Alkaline 
Phosphatase in Rabbits 
I 
p 
Tibial Fracture in Rabbits Introduction 
Introduction 
Alkaline phosphatases constitute a system of enzymes with 
multiple molecular forms. They originate from various organs including 
liver, bone, kidney, placenta and small intestine. Some of them differ by 
their primary sequence as a result of translation from different genetic 
loci, e.g., the placental, intestinal and the tissue non-specific ALP. 
Others differ from one another by the post-translational modification 
(different degree of glycosylation), e.g., the skeletal, hepatic and renal 
ALP; hence they are not true isoenzymes but isoforms. 
Alkaline phosphatase activities are observed in serum as a 
result of the release into the circulation by the cells synthesizing them 
during cell turnover. The level of total ALP activity in serum has been 
shown to be elevated in many disease status. Therefore, determination 
of the elevated ALP isoenzymes in serum is important to identify the 
source leading to the elevation of total ALP activity in serum; thereby, 
the diagnosis of diseases. 
The serum bone-specific ALP activity has long been regarded 
as an index of osteoblastic activity in the skeleton. The increase in the 
serum level of bone-specific ALP has also been referred to as increasing 
osteoblastic activity in bone. Since the primary function of osteoblast is 
bone formation (osteogenesis), increase in serum bone-specific ALP, 
therefore, are observed in pubertal growth spurt of bone, in malignant 
bone forming tumor and in bone fracture healing in which the increase in 
osteoblastic activity is important to form new bone around the fracture 
site. 
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In the present study, the plasma levels of bone-specific ALP 
were measured in regular interval to investigate the relationship between 
the bone-specific ALP activity discharged into the plasma by the 
osteoblasts and the healing of a fracture at different stages that would be 
monitored by X-ray radiography. The expression of bone-specific ALP 
activity in the callus would also be measured. This is used to determine 
whether it can act as a marker to monitor the progress of bone fracture 
healing. 
Results 
3.1 NORMAL CURVE FOR PLASMA BONE-SPECIFIC ALP IN 
RABBITS 
The levels of plasma bone-specific ALP from week 30 to week 
64 from rabbits in a group of 4 was shown in Fig. 3-1. From the figure, 
a steady decreasing trend in the plasma level of bone-specific ALP from 
week 30 to week 40 was observed. In addition, the levels in the plasma 
samples from these weeks showed large deviation and it seemed to slow 
down decreasing and level off after 42 weeks. In the present study, 
rabbits chosen for the bone fracture operation fell,into three age groups, 
the immature group, aged between 30 weeks and 35 weeks, the 
premature group, aged at 36 weeks and the mature group, aged at 45 
weeks. The fluctuation in the points from week 58 to week 64 might be 










































































































































































































































































Tibial Fracture in Rabbits Results 
3.2 THE EFFECTS OF TIBIAL FRACTURE ON THE PLASMA 
LEVEL OF BONE-SPECIFIC ALP IN RABBITS 
Fig. 3-2 showed the effects of tibial fracture on the plasma 
bone-specific ALP activities in rabbits of immature group (aged 30 - 35 
Plasma Bone-specific , 
ALP Level (U/L) " " " Exper,mental 
• Operational Control 
«« 
3 5 
30 - T 
10 - . 
5 I I 1 1 
0 2 4 6 8 
Post-fracture Time (Weeks) 
Fig. 3-2 Effects of tibial fracture on the plasma level of bone-specific 
ALP. Groups of rabbits (aged between 30-35 weeks) were subjected to tibial 
fracture operation and operational control at week 0. Blood were sampled 
weekly for the first two weeks and biweekly for the subsequent 6 weeks. 
Plasma were subjected to routine bone-specific alkaline phosphatase assay. 
Points represent mean i values of plasma bone-specific alkaline phosphatase 
of 6 samples SD. One rabbit in the experimental group died at sometime 
between week 4 and week 6. So the points at week 6 and week 8 in the 
experimental group represent the mean values of 5 plasma samples. The 
tibiae of two rabbits in the experimental group showed bacterial infection 
when they were removed at week 8. 
* : marginally significant difference, 0.02 <P< 0.05. 
marginally significant difference, 0.01 < P < 0.02. 
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weeks). The experimental group and the operational control group did 
not differ very significantly from week 0 to 4. The levels of plasma 
bone-specific ALP at week 6 and week 8 showed marginally significant 
difference (week 6: 0.02<P<0.05; week 8: 0.01<P<0.02). The levels in 
the operational control group did not show great fluctuation (values 
between 13.95 U/L and 19.69 U/L from week 0 to 8). On the contrary, 
an increasing trend was observed in the experimental group from week 1 
to week 6. A drastic drop of the level was observed just after the 
operation and week 1. The level then increased gradually reaching a 
peak at week 6. The difference between the highest level at week 6 and 
the lowest level at week 1 was significant (P<0.001). 
In the experimental group, one rabbit died at sometime 
between week 4 and week 6 and the tibiae of two rabbits were ununited 
and contained soft yellow tissue resembling pus. These two tibiae might 
be infected by bacteria. For the sake of the accurate determination of 
plasma bone-specific ALP, the data obtained from these two rabbits 
were rejected and the profile devoid of these two rabbits was shown in 
Fig. 3-3. The figure showed that the infection did not have many effects 
on the plasma bone-specific ALP level when comparing with the profile 
on Fig. 3-2. A drastic drop was also observed in the experimental group 
between week 0 and week 1 and then rose gradually; peak value 
observed at week 6 Levels at week 8 of both.groups also exhibited 
marginally significant difference. 
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Plasma Bone-Specific — • ~ Experimental 
ALP Level (U/L) q — Operational Control 
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Fig. 3-3 Effects of tibial fracture on the plasma level of bone-specific 
ALP. Values from two rabbits showing infection were rejected. The points in 
the operational control group were means of six values ± SD and those in the 
experimental group from week 0 to week 4, means of 4 values SD, and 
from week 6 to week 8, means of 3 values SD. 
marginally significant difference, 0.02 < P < 0.05. 
3.3 PROFILE OF THE PLASMA ALP LEVEL UPON HEALING 
OF TIBIAL FRACTURE 
The profiles of plasma ALP activities .upon healing of tibial 
fracture in the rabbits operated at 36 weeks (the premature group) and at 
45 weeks (the mature group) are shown in Fig. 3-4 and Fig. 3-5 
respectively. Blood samples were taken weekly and rabbits were 
sacrificed at 2-week interval. As shown in Fig. 3-4 there was an initial 
drop of plasma bone-specific ALP from week 0 to week 1 as in the 
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Plasma ALP 
Level (U/L) 0 — Bone-specific ALP 
Q n n ~ • ~ Total ALP 9 0
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Fig. 3-4 Changes in the plasma total ALP and bone-specific ALP levels 
at different stages of healing of tibial fracture in the premature group. 
Twelve rabbits underwent the surgery of tibial fracture at the age of 36 
weeks. Plasma were sampled weekly and subjected to total ALP and bone-
specific ALP assays, Numbers in the parenthesis are the numbers of sample 
used for the corresponding point. Results are mean ± SD. 
previous experiment, and then gradually rose reaching maximum at 
week 7. After week 7, steady decrease in the plasma bone-specific ALP 
was observed. It was interesting that the maximum level at week 7 was 
comparable to the pre-operational level. In other words, the plasma 
bone-specific ALP (dropped to a low level after fracture and the level 
rose gradually back to the pre-operational level and dropped again 
approaching to the level at week 1 as if the base line lied on the level at 
week 1. 
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Fig. 3-4 also showed the profile of plasma total ALP activity 
as a reference. As in the bone-specific ALP, an initial drop was 
observed probably being due to the drop of bone-specific ALP activity. 
Similar pattern was observed in both ALP levels. However, the decline 
in total ALP beyond week 7 were not so obvious as the bone-specific 
ALP. Similar pattern was also found in the mature group (Fig. 3-5). 
Initial drop was also observed at week 1 and peak value at week 7. Both 
groups had shown that plasma total ALP might be a less potent marker 
than the bone-specific ALP as to monitor the progress of fracture 
healing. 
Plasma ALP ——o~ Bone-specific ALP 
Level (U/L) ~ • ~ Total ALP 
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Fig. 3.5 Changes in the plasma total ALP and bone-specific ALP levels 
at different stages of healing of tibial fracture in the mature group. 
even rabbits underwent the surgery of tibial fracture at the age of 45 
weeks. Plasma were sampled weekly and subjected to total ALP and bone-
specific ALP assays. Numbers in the parenthesis are the numbers of sample 
used for the corresponding point. Results are mean ± SD. 
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3.4 RADIOGRAPHY 
Fractured leg of one rabbit planned to be sacrificed at week 16 
was subjected to radiography biweekly. Anesthetization of the rabbit 
was required when the radiograph was taken each time. Photo 3-1 was 
the radiograph taken at week 2. The two bars in the bone marrow were 
the intramedullary nails. Typical fibrocartilaginous callus was observed. 
The fracture site did not show any sign of union. At week 4 the callus 
had been converted into bony callus (Photo 3-2) as shown by the higher 
density of the callus. The fractured bones were still ununited at this 
week. At week 6 a little change was observed on the callus. The 
fractured bone showed sign of union but incompletely at this week 
(Photo 3-3). At week 8, great improvement was observed. The 
fractured bone had been united (Photo 3-4). Not many changes of the 
callus were noticed in the subsequent weeks. The bone had been 
completely replaced by lamellar compact bone after week 8 and the 
I ^ ^^^^^^^^^^^^^^^^^^^^^^^^  I 
Photo 3-1 Week 2 
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callus was shown to become smaller (Photo 3-5 and Photo 3-6). The 
radiograph of the tibia removed at week 16 demonstrated the complete 
union of the fracture site (Photo 3-7). 
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3.5 PROFILE OF CALLUS BONE-SPECIFIC ALP ACTIVITY 
UPON HEALING OF TIBIAL FRACTURE 
Twenty-three tibiae were removed at two-week interval after 
fracture. The calluses were homogenized and extracted with 0.1 M 
sodium borate buffer (pH 7.03) at 4°C overnight. The extracts, being 
diluted 100 folds, were assayed for the bone-specific ALP activities by 
Bone-Specific ALP 
Activity (U / g bone) 
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Fig. 3-6 Changes in the bone-specific ALP levels in calluses at different 
stages of tibial fracture healing in rabbits. Groups of 23 rabbits (of which 
12 rabbits were 36 weeks old and 11 were 45 weeks old) were sacrificed at 
two-week interval to obtain calluses healed at different stages after fracture. 
Calluses were homogenized and extracted with 0.1 M borate buffer. Aliquots 
in appropriate dilution were taken for bone-specific ALP assay. The ALP 
extracted were essentially the bone-specific ALP (> 90% of total ALP): 
Wherever indicated, the points represent the mean values of 3 samples ± 
SD, except: 
point (a): value from one sample; and 
point (b): mean value from 4 samples ± SD 
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COBAS BIO autoanalysor. 
The specific activities of callus bone-specific ALP (U/g bone) 
at various time of fracture healing was shown in Fig. 3-6. The ALPs 
extracted from the callus were essentially the bone-specific isoform 
(92.76 3.59%). An exponential decline of the specific activity was 
demonstrated with the half-life of about two weeks. From week 10 to 
week 16 no obvious decrease of the specific activity was observed. 
It was worth mentioning that the callus removed from the 
rabbit at week 2 was formed incompletely; the size of the callus was 
very small. Besides, those removed from week 4 to week 6 were 
composed entirely of soft bone which could easily be scraped out by 
fingers. They exhibited the typical structure of woven bone. On the 
contrary, the calluses removed beyond week 8 were composed entirely 
of hard, compact bone, the lamellar bone. In other words, high bone-
specific ALP activities were found in callus in the early bony callus 
stage consisting mainly of woven bone. Bone-specific ALP activities 
were demonstrated to be very low in the late bony callus stage or in the 
stage of remodeling in which the bone is mainly composed of lamellar 
bone. 
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Discussion 
To investigate the effects of bone fracture on the plasma level 
of bone-specific ALP requires a minimum steady baseline or 
backgrounds. Since the physiologic increase of bone-specific ALP in 
puberty would override or complicate the effect of fracture healing, it is 
absolutely crucial to execute the fracture operation after the plasma 
bone-specific ALP has leveled off. This was the objective to construct 
the normal curve. Generally, rabbits aged beyond 30 weeks might be 
regarded as adults (Ring, 1955) which should have lowest level of 
plasma bone-specific ALP. However, Fig. 3-1 gave us the information 
that the levels of plasma bone-specific ALP from week 30 to week 40 
were still decreasing and had not reached a steady level. As a result, 
rabbits aged between 30 weeks and 40 weeks were not suitable for the 
operation due to the high level of plasma bone-specific ALP indicating 
that the rabbits were still not mature. It could be revealed by the large 
deviation of the data obtaining from samples from week 30 to week 40. 
The large deviation indicated that the levels of plasma bone-specific 
ALP might still be very high in some rabbits. The figure further showed 
that the plasma bone-specific ALP seemed to level off after 42 weeks. 
Concerning the enzymatic level, it seems better to choose rabbits beyond 
43 weeks for the fracture operation. In the present study, however, three 
groups of rabbits in different degree of maturity with respect to the 
plasma levels of bone-specific ALP were used to investigate the 
influence of ages on the profile of plasma bone-specific ALP activities 
upon a fracture healing. Results showed no difference on the profile 
among three groups (Fig. 3-2, Fig. 3-3 and Fig. 3-4). The profiles of 
three groups of rabbits all showed an initial drop of the plasma level of 
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bone-specific ALP one week after fracture. The levels then gradually 
rose reaching a peak value at week 7 and dropped steadily to a low level 
after this week. To use the immature, premature and mature groups of 
rabbits to study the effect of fracture healing on the change of bone-
specific ALP is of clinical relevance since these groups form models of 
fracture healing at different age groups in patients. 
The rationale for the use of female rabbits for the operations 
bases on the usual observation that female animals are more sufferable to 
traumatic surgery. We had demonstrated that there was no sex 
difference on the plasma bone-specific ALP levels in rabbits after 
fracture operation (data not shown). 
An initial drop of the plasma bone-specific ALP level was 
frequently observed one week after the operation regardless the sex and 
the age. This may be accounted for by the hormonal regulation. Since 
body responds to trauma, hormones secreted such as ACTH and Cortisol 
may have some effects on the regulation of osteoblastic activity leading 
to a drop of the plasma ALP level (Greenspan, 1991). 
Two rabbits showed infection in the experiment on the 
investigation of the effect of tibial fracture on the level of bone-specific 
ALP in immature group (i.e. in Fig. 3-2). It is not surprising since the 
fracture operation simulates the condition of open fracture. Open 
fracture has been shown to be prone to infection due to the direct 
communication between the fracture site and the exterior of the body. 
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Osteomyelitis (infection of bone) may lead to the non-union of 
the fracture. Radiological findings demonstrate the rounded and 
sclerotic fracture site and there may be signs of the attempted formation 
of a false joint (Adams, 1978). The lipopolysaccharide (LPS) on the 
bacterial cell wall may be a cause of non-union in osteomyelitis if the 
bone is infected by Gram-negative bacteria. LPS had been demonstrated 
to inhibit collagen synthesis and induce bone resorption, which may be 
mediated through TNFa (tumor necrosis factor a) released by the LPS-
activated macrophages (Saklatvala, 1986; Harvey et al, 1986). This adds 
complication to bone fracture clinically. However, we found that 
osteomyelitis did not have obvious effect on the plasma level of bone-
specific ALP in fractured rabbits (Fig. 3-3). 
Fig. 3-4 and Fig. 3-5 showed the profiles of the levels of 
plasma bone-specific ALP as a function of time in premature and mature 
group respectively. A peak value was observed at week 7 in both groups 
and it must have been a critical point in the progress of fracture healing. 
Plasma levels of bone-specific ALP kept on increasing before week 7 
and decreasing after this point. Radiographic analysis showed that union 
of the fracture site occurred sometime between week 6 and week 8 
(Photo 3-1 to Photo 3-7). Therefore, it is reasonable to draw a 
conclusion that union of the fracture site has occurred when the plasma 
bone-specific ALP level start to decline. The rise of the ALP level 
before week 7 might be explained by the fact that woven bones were 
deposited between week 1 and week 7 in the early bony callus stage. 
High osteoblastic activities were observed in this stage; bone-specific 
ALP was continuously secreted into the circulation. It was necessary 
since healing of a bone fracture requires to build up a rigid scaffolding 
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(of woven bone) to fix the position of the fracture site for the subsequent 
repair. After week 7 the woven bone was subsequently and gradually 
replaced by lamellar bone and the callus was entering into the late bony 
callus stage. Osteoblastic activities thus commenced to decline leading 
to the lower discharge of ALP into the circulation. Continuous 
remodeling of the callus should therefore lead the plasma bone-specific 
1
 ALP back to the normal low level. 
High bone-specific ALP activity was also observed in the 
callus composing mainly of woven bone, which was found in the callus 
before 8 week (Fig. 3-6). As soon as the replacement of woven bone by 
lamellar bone occurred, bone-specific ALP expressed in the callus had 
dropped to a very low level. Apart from this, osteoblastic activity was 
shown to be very high at week 2 indicated by the highest bone-specific 
ALP in callus. It was not surprising since it was in the early bony callus 
stage in which large amount of calcium phosphate had to be deposited 
for the building of the scaffolding. 
In conclusion, bone-specific ALP can act as an index to 
monitor the progress of the healing of tibial fracture in rabbit. The 
plasma level of bone-specific ALP can be used to determine whether the 
fracture had united or not. The bone-specific ALP levels in the callus 
also reflect the osteoblastic activities; high level exists in the woven 
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Introduction 
The changes in the plasma levels of bone-specific ALP in 
experimentally produced fracture in rabbits have been studied in the 
previous chapter. In the present chapter, the studies of the plasma bone-
specific ALP activities are focused on local patients. With the wheat 
germ lectin precipitation method, the plasma levels of bone-specific 
ALP would be determined in 85 normal Chinese adults, 49 adults with 
long bone fractures and 15 patients with osteosarcoma. 
Results 
4.1 NORMAL VALUES 
The levels of plasma bone-specific alkaline phosphatase in 
normal male adults and normal female adults are shown in Table 4-1. 
The normal values of the plasma bone-specific ALP activity in male 
Table 4-1 Plasma bone-specific ALP activities in normal male and 
female adults and osteosarcoma-bearing patients 





Osteosarcoma Patients 680.5±151.53c — 
85 normal adults were aged between 20 and 60. 
i a: n=49 
b: n=36 
c: n=15. P < 0.001 
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adults was 39.76 16.68 U/L and in female adults was 31.36 12.41 U/L. 
Normal range is 23 to 56 U/L. 
4.2 FRACTURE GROUP 
The changes in the plasma level of bone-specific ALP in 
patients with single long bone fracture are shown in Fig. 4-1. A gradual 
rise in the plasma bone-specific ALP levels was observed after fracture. 
Significant increases in the activities were noted in the period from week 
5 to week 15 (P < 0.05). Peak value lied between week 8 and week 12. 
After week 15 the increase in the levels was insignificant and the 
Plasma Bone-specific 
ALP Activity (U/L) 




Q 4- . 1 1 1 • 1 ' 1 ' ' 
o 5 10 15 20 25 30 
» 
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R g . 4-1 Profile of plasma bone-specific alkaline phosphatase activities 
in patients during fracture healing. The bone-specific ALP activities of the 
plasma samples from 49 patients with single long bone fracture were 
determined. Points represent mean SD. ‘ 
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enzyme levels returned to normal values from week 24 to week 30. The 
rise in the activity after fracture and the persistent high levels during the 
healing phase were seen in 93.9% of this group of patients. 
4.3 BONE TUMOR GROUP 
The plasma ALP levels in patients with osteosarcoma are 
shown in Table 4-1. Results showed a significant increase in the plasma 
bone-specific ALP in patients bearing osteosarcoma (P < 0.001) 
comparing with normal values. 
Discussion 
The plasma levels of bone-specific ALP in normal adults (age 
20-60) change insignificantly according to sex and they were within the 
normal range of 23-56 U/L (Table 4-1). The present study dealed with 
the patients with single closed fracture of long bones. Results 
demonstrated an increase in the plasma levels of bone-specific ALP in 
these patients. Peak values were observed between week 8 to week 12. 
The levels subsequently declined reaching to the normal values after 24 
j
 weeks. This finding was similar to that in the experiment done on 
rabbits (Chapter 3). However, no initial drop of the activities was 
observed in these patients (refers to Fig. 3-2 to Fig. 3-5). Moreover, the 
changes in the plasma bone-specific ALP activities in the patients after 
fractures did not lead to any variation in the plasma liver ALP activities 
(result not shown). Since this result was derived from the data of 49 
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patients with different fractures and methods of treatments, the 
heterogeneity of the data might be difficult to draw conclusion for the 
clinical application with this investigation. Further study should be done 
with more uniform patient demography, fracture pattern and treatment 
modality. 
The use of plasma total ALP activity in monitoring malignant 
bone tumors had been reported (Bacci et al, 1987). However, the lack of 
specificity and the common association with the increase in the alkaline 
phosphatase activity in liver tissue, especially with metastatic tumor, 
lead to the inaccurate determinations (Mayne et al, 1987). In the present 
study, the plasma bone-specific ALP levels were determined in patients 
with osteosarcoma. Results demonstrated a statistically significant 
increase (P < 0.001) in the activities in this kind of bone-forming tumor. 
This finding is reasonable since osteosarcoma are expected to contain 
high alkaline phosphatase content (for experimental proof, refers to Fig. 
5-4 in Chapter 5). Therefore, the sensitive and specific determination of 
the plasma level will be of clinical significance in the monitoring the 
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Introduction 
In the previous chapters, investigations of the relationship 
between the bone-specific ALP levels and bone diseases were done in 
animal model and in local patients. A generally accepted drawback of in 
vivo studies is the presence of individual variation and uncontrollable 
complications, e.g., osteomyelitis in bone fracture (Fig. 3-2 in our 
experimental study). Coexistence of other diseases and hormonal 
regulation may also complicate the picture when patients are studied in 
clinical examination. The problem of individual variation can be 
resolved by increasing the sample size. However, when a problem of the 
availability of animals is encountered, the study may suffer from large 
deviations resulting in a lower reliability. Therefore, in vitro studies of 
the corresponding bone cell type are necessary in order to reduce the 
influence by other cell types or hormones. In additions, in vitro culture 
permits precise measurements of the parameters in interest with a higher 
reproducibility, thereby a higher reliability. 
Bellows ^ al in 1986 described a method to isolate osteoblast-
like cells from fetal rat calvaria by sequential collagenase digestion. The 
cells isolated have been shown to be viable and possess many 
characteristics resembling typical osteoblasts. They are capable of 
synthesizing and secreting type I collagen. , In the presence of 
appropriate artificial substrates, mineralization occurs in the culture 
vessels in the form of calcified three-dimensional nodules which can be 
visualized by von Kossa staining of calcium deposits. In additions, the 
osteoblast-like cells isolated by collagenase digestion of calvaria have 
been shown to be responsive to PTH, PGs, 1,25-DHCC and 
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glucocorticoid. Expression of alkaline phosphatase activity and other 
bone-associated proteins such as osteocalcin (Hauschka et al 1975; 
Price et al, 1976) and osteonectin (Termine et al, 1981) were also 
demonstrated. 
As shown in Section 1.4, rat osteosarcoma cell line UMR-106 
' belongs to the osteoblastic type. They were also shown to secrete 
alkaline phosphatase activities and express type I collagen. Hormone 
responsiveness to PTH, PGs and 1,25-DHCC was also demonstrated. 
Therefore, UMR-106 and calvarial osteoblast-like cells might be used as 
in vitro models to study the osteoblastic characters. 
In the present study, several aspects of bone-specific ALP 
were studied in the osteoblast-like cells released by collagenase 
digestion of fetal rat calvaria and in UMR-106 osteosarcoma cell line. 
Changes of cellular contents of bone-specific ALP would be determined 
during the long term culture. Since the primary function of osteoblasts is 
to form bone and in vitro mineralization had already been demonstrated 
in both cell types, the relationship between ALP expression and the 
calcification would be investigated on qualitative examination and 
quantitative measurements of the calcium and inorganic phosphate 
deposition in the presence and the absence of artificial substrates. Due 
to the observation' of bone-specific ALP actiyities in the serum, 
osteoblasts should be able to secrete ALP into the bone fluids and 
somehow the ALP enters into the blood stream. This property would be 
studied by the release of bone-specific ALP into the culture medium and 
the levels during the culture period would be investigated in both cell 
types. Alkaline phosphatase had been shown to be a membrane bound 
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enzyme expressed on the cell surface. Unlike the usual membrane-
bound enzymes having a hydrophobic core anchoring into the 
hydrophobic region of the lipid bilayer, ALP was covalently attached to 
the phosphate group on the membrane lipid situated at the outer surface, 
the ectoenzyme. Therefore, changes on the cell surface ALP would also 
be studied. Collagen synthesis is a prerequisite of osteogenesis and has 
long been considered as an index of bone formation. In the present 
study, the relation between bone-specific ALP levels and the rates of 
collagen synthesis would be investigated. 
» 
Results 
5.1 IN VITRO MINERALIZATION OF UMR-106 CELLS AND 
PRIMARY RC CELLS 
UMR-106 cells were seeded to 75 cm2 culture flask 
(CORNING) and cultured with 10% FBS containing DMEM standard 
medium at 37°C (5%C02 / 95% air). Medium was refreshed every 2 
days. After confluence, the monolayer was further cultured for 5 days. 
Medium was subsequently changed into 10% FBS containing DMEM 
supplemented medium. Mineralization was allowed to occur for 6 days 
with medium refreshment at 2-day interval. After 6-day mineralization, 
monolayer was fixed with 10% NBF overnight and stained for calcium 
by von Kossa technique. 
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Photo 5-1 In vitro mineralization of UMR-106 cells. Cells were cultured 
with 10% FBS containing DMEM standard medium and exposed to 10% FBS 
containing DMEM supplemented medium for mineralization to occur for 6 
days. (A) Calcified nodules appeared as three-dimensional black dots after 
silver staining for calcium by von Kossa technique. (B) Same culture flask 
with higher magnification. 
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Photo 5-1 shows the mineralized nodules after staining for 
calcium by von Kossa techniques. Mineralized nodules were observed 
as 3-dimensional black dots with the diameter of about 2 mm. Photo 5-2 
showed the 3-dimensional mineralized nodules before staining. 
Mineralized nodules are white due to the presence of white 
hydroxyapatite crystals. Attempts have been made on the culture of 
UMR-106 cells with 10% FBS containing DMEM supplemented 
medium. Results showed that UMR-106 cells were not adaptive to the 
supplemented medium. Cell death was observed after confluence. The 
remaining cells were not capable of forming 3-dimensional nodules and 
mineralization occurred as a thin smear as shown in Photo 5-3. 
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Photo 5-2 (A) 
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Photo 5-2 (B) 
Photo 5-2 Mineralized nodules formed by UMR-106 cells before 
staining. (A) Mineralized nodules were white dots due to the presence of 
hydroxyapatite crystal. (B) Same culture flask with higher magnification. 
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Photo 5-3 (B) 
Photo 5-3 In vitro mineralization of UMR-106 cells. Cells were cultured 
with 10% FBS containing DMEM supplemented medium. Cell death was 
observed in the present study and the residual cells were incapable of 
forming three-dimensional nodules. (A) Calcium deposits were stained as a 
thin smear. (B) Same culture flask with higher magnification. 
Investigation of in vitro mineralization of primary RC cells 
had been carried out. Confluent monolayer of primary RC cells was 
subcultured and seeded at the concentration of 1x10s cells I well into 6-
well plate. Cells in well no. 1 to 3 were cultured with 15% FBS 
containing aMEM standard medium and those cells in well no. 4 to 6, 
with 15% FBS containing aMEM supplemented medium. Medium was 
refreshed every two days and the cells were cultured for 21 days at 37°C 
(5%C02 / 95% air). After 21-day culture, cells were fixed with 10% 
NBF overnight and subjected to von K6ssa staining for calcium. 
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Photo 5-4 In vitro mineralization of primary RC cells. Cells were cultured 
with 15% FBS containing aMEM standard medium (well no. 1-3) and 16% 
FBS containing aMEM supplemented medium (well no. 4-6). Mineralization 
occurred only in the presence of artificial substrate, p -glycerophosphate. 
Note that very minute amount of calcium were stained in well no. 2. 
Photo 5-4 shows the results of in vitro mineralization of 
primary RC cells. The results were apparent that those cells cultured, 
with 15% FBS containing aMEM standard medium did not mineralize 
as they were negatively stained for calcium deposits. In well no. 4 to 6, 
the cells being cultured with aMEM supplemented medium, 
mineralization occurred as they could be stained' for calcium. It was 
noted that the sizes of mineralized nodules produced by primary RC 
cells were always smaller than those produced by the UMR-106 cells. 
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5.2 STUDY OF BONE-SPECIFIC ALP RELEASED INTO 
MEDIUM BY UMR-106 CELLS AND PRIMARY RC CELLS 
Confluent monolayer of UMR-106 cells was subcultured and 
seeded to 6-well plates at 1x10s cells / well in DMEM plain medium. 
After an overnight culture, medium was changed to 10% FBS containing 
DMEM standard medium or supplemented medium. Media were saved 
and refreshed at 2-day interval. Cultures with 10% FBS containing 
DMEM standard medium were terminated at 16 days and those with 
10% FBS containing DMEM supplemented medium, at 8 days. 
The studies for the primary RC cells were similar to those for 
UMR-106 cells. The confluent monolayer of primary RC cells Was 
subcultured and seeded to 6-well plate at lxlO4 cells I well with 0.75% 
aMEM standard medium. The plate was incubated at 37 C (5%C02 / 
95% air) overnight. The medium was replaced by 15% FBS containing 
aMEM standard medium and cultured for 20 days with the refreshment 
of the medium at 2-day interval. Conditioned media were saved for the 
C' : 
estimation of bone-specific ALP released into the medium. During each 
time of media refreshment, 1 mL of the corresponding fresh medium was 
co-incubated for the estimation of background bone-specific ALP 
activity arising from fetal bovine serum. 
1 
» 
Fig. 5-1 shows that the bone-specific ALP released into the 
medium in cultures of UMR-106 cells with 10% FBS containing DMEM 
standard medium increased gradually from day 2 to day 8. A large 
increase was then observed at day 10. The subsequent levels were 
maintained without significant changes. It was noticed that UMR-106 
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Fig. 5-1 The levels of bone-specific ALP released into the medium by 
UMR-106 cells. UMR-106 cells were cultured with 10% FBS containing 
DMEM standard medium. Conditioned media were saved for the estimation 
of bone-specific ALP by COBAS BIO autoanalysor. Results are mean SD 
(n=6). 
cells reached confluence at 6-8 days after the start of culture with 10% 
FBS containing DMEM standard medium. Fig. 5-2 demonstrates the 
bone-specific ALP released into the medium in UMR-106 cells cultured 
with 10% FBS containing DMEM supplemented medium rose gradually. 
The levels were comparable to those cultured with standard medium. 
I 
This revealed that the presence of artificial substrates did not stimulate 
the release of bone-specific ALP in UMR-106 cells. 
The bone-specific ALP released into the medium by primary 
RC cells cultured with 15% FBS containing aMEM standard medium is 
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Fig. 5-2 The levels of bone-specific ALP released into the medium by 
UMR-106 cells. UMR-106 cells were cultured with 10% FBS containing 
DMEM supplemented medium. Conditioned media were saved for the 
estimation of bone-specific ALP by COBAS BIO autoanalysor. Results are 
mean SD (n=6). 
shown in Fig. 5-3. Primary RC cells reached confluence at day 6. It was 
noticed that no bone-specific ALP was released into the medium before 
day 4 whereas the enzyme was secreted after confluence. When 
comparing to Fig. 5-1, it was not difficult to observe that the amount of 
bone-specific ALP released into the medium by UMR-106 cells was 
i 
much higher than that released by primary RC cells (maximum amount 
around 1000 mU vs. 20 mU). 
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Fig. 5-3 The levels of bone-specific ALP released into the medium by 
primary RC cells. Primary RC cells were cultured with 15% FBS containing 
aMEM standard medium. Conditioned media were saved for the estimation 
of bone-specific ALP by COBAS BIO autoanalysor. Results are mean ± SD 
(n=6). 
5.3 STUDY OF CELLULAR ALP ACTIVITIES AND CALCIUM 
PHOSPHATE DEPOSITS 
Confluent monolayer of UMR-106 cells was subcultured and 
i 
seeded at 1x10s cells I well to 6-well plates with DMEM plain medium. 
The cultures were incubated at 37 C (5%C02 / 95% air) overnight. 
After an overnight culture, the medium was changed into 10% FBS 
containing DMEM standard medium or 10% FBS containing DMEM 
supplemented medium. The media were refreshed at 2-day interval and 
the cultures were terminated at day 6, day 12 and day 18 for the 
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estimations of cellular bone-specific ALP activities from well no. 4 to 6 
and cell surface ALP activities and the amount of calcium phosphate 
deposits from well no. 1 to 3 as described in Materials and Methods. 
The studies for primary RC cells were similar to those of 
UMR-106 cells. Confluent monolayer of primary RC cells was 
subcultured and seeded to 6-well plates at lxlO4 cells / well with aMEM 
plain medium. The cultures were incubated at 37°C (5%C02 / 95% air) 
overnight. The medium was aspirated and changed to 15% FBS 
containing aMEM standard medium or 15% FBS containing aMEM 
supplemented medium. Media were refreshed at 2-day interval. Plates 
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Fig. 5-4 The levels of cellular bone-specific ALP activities in UMR-106 
cells and primary RC cells cultured with standard medium and 
supplemented medium. Results are mean SD (n=3). Vanishing error 
bars represent the SD are less than the heights of the symbols. Std = 
standard medium; Supp = supplemented medium. 
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were removed at day 6 day 12 and day 18 for the estimation of cellular 
bone-specific ALP activities from well no. 4 to 6 and cell surface ALP 
activities and calcium phosphate deposits from well no. 1 to 3. 
Changes of cellular bone-specific ALP specific activities (U/g 
protein) in UMR-106 osteosarcoma and in primary RC cells are plotted 
on Fig. 5-4. The present study showed that UMR-106 cells were not 
well grown in 10% FBS containing DMEM supplemented medium. The 
rates of cell growth were lower than those cells cultured with 10% FBS 
containing DMEM standard medium and cell death was apparent after 
being cultured for 8 days (data not shown). Therefore, the cellular bone-
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Fig. 5-5 The levels of inorganic phosphate deposited by UMR-106 cells 
in standard medium and primary RC cells in standard medium and 
supplemented medium. Results are mean ± SD (n=3). Vanishing error 
bars represent the SD are less than the heights of the symbols. Std = 
standard medium; Supp = supplemented medium. 
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specific ALP activity after day 12 was not determined in culture with 
supplemented medium. Fig. 5-4 demonstrated that the cellular bone-
specific ALP activities in UMR-106 cells and in normal primary RC 
cells increased steadily. No significant difference was observed in cells 
cultured with standard medium or supplemented medium despite the 
observation of cell death in UMR-106 cells cultured with supplemented 
medium. However, the bone-specific ALP activities in UMR-106 cells 
were always significantly higher than those in primary RC cells. 
The amount of inorganic phosphate deposited by UMR-106 
cells and primary RC cells cultured with standard medium or 
supplemented medium are plotted in Fig. 5-5. Results showed that the 
amount of inorganic phosphate deposited by primary RC cells cultured 
with standard medium did not change significantly along the culture 
period. A dramatic increase in the inorganic phosphate deposits was 
observed after 12 days in primary RC cells cultured with supplemented 
medium. No significant changes in inorganic phosphate deposits were 
observed in UMR-106 cells cultured with standard medium and even 
there was an unexpected reduction in the deposits at day 18. Inorganic 
phosphate deposits were not quantified in UMR-106 cells cultured with, 
supplemented medium due to the cell death. As in the bone-specific 
ALP activities, the amount of inorganic phosphate deposited by UMR-
106 cells was always significantly higher than that by primary RC cells 
whichever media were used. 
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Fig. 5-6 The levels of calcium deposited by primary RC cells in 15% FBS 
containing aMEM standard medium and supplemented medium. 
Results are mean ± SD (n=3). Vanishing error bars represent the SD are 
iess than the heights of the symbols. Std = standard medium; Supp = 
supplemented medium. 
The amount of calcium deposited by primary RC cells cultured 
with standard medium or supplemented medium are plotted in Fig. 5-6. 
The figure shows that the levels of calcium deposits paralleled those of 
the inorganic phosphate deposited by the primary RC cells. The calcium 
t 
deposited by the primary RC cells cultured with' 15% FBS containing 
aMEM supplemented medium was dramatically increased after day 12 
and no significant changes were observed in culture with standard 
medium. The differences of the levels between primary RC cells 
cultured with standard medium and supplemented medium at day 18 
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were significant. The correlation between the cellular bone-specific 
ALP activities and the calcium phosphate deposits was reflected in the 
primary RC cells cultured with supplemented medium (Fig. 5-5 and Fig. 
5-6). We can observe a proportional relationship between the amount of 
calcium phosphate and the cellular bone-specific ALP activities in the 
primary RC cells cultured with supplemented medium. Moreover, we 
also found that high level of cellular bone-specific ALP activities in 
UMR-106 cells always leads to the higher amount of phosphate 
deposition (Fig. 5-4 and Fig. 5-5). 
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Fig. 5-7 The cell surface ALP activities in UMR-106 cells and primary 
RC cells. UMR-106 cells were cultured with 10% FBS containing DMEM 
standard medium. Primary RC cells were cultured with 15% FBS containing 
otMEM standard medium and supplemented medium. Results are mean 
SD (n=3). Vanishing error bars represent the SD are less than the heights of 
the symbols. Std = standard medium; Supp = supplemented medium. 
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The cell surface ALP activities in culture of UMR-106 cell 
with 10% FBS containing DMEM standard medium and of primary RC 
cells with 15% FBS containing aMEM standard medium and 
supplemented medium are plotted in Fig. 5-7. The level changes in 
primary RC cells were similar to those of cellular bone-specific ALP 
(see Fig. 5-4). A gradual increase was also observed in primary RC ceils 
cultured with either medium. However, the levels of cell surface ALP 
did not correlate to that of cellular bone-specific ALP in UMR-106 cells. 
Since UMR-106 cells were not well grown in 10% FBS 
containing DMEM supplemented medium, duration of medium exposure 
to supplemented medium was reduced so as to investigate the effects of 
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Ffg. 5-8 The levels of cellular bone-specific ALP in UMR-106 cells. 
UMR-106 cells were cultured with 10% FBS containing DMEM standard 
medium for 4 and 6 days. Mineralization was allowed to occur for 2 days. 
R e s U l ts are mean ± SD (n=3). Std = standard medium; Supp = 
supplemented medium. 
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the artificial substrate on mineralization of UMR-106 cells. Confluent 
monolayer of UMR-106 cells was subcultured and seeded at lxlO5 cells 
in 6-well plates with DMEM plain medium. The cultures were 
incubated at 37 C (5%C02 / 95% air) overnight. Medium was changed 
into 10% FBS containing DMEM standard medium and refreshed at 2-
day interval. At day 4 and day 6 the cultures were exposed to 10% 
FBS containing DMEM supplemented medium for 2 days to allow 
mineralization. In other words, cultures were terminated at day 6 and 
day 8 to quantify cellular bone-specific ALP contents in well no. 4-6 and 
calcium phosphate deposits in well no. 1-3. 
Fig. 5-8 shows that the cellular bone-specific ALP contents 
increased from day 6 to day 8. No significant difference was observed in 
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Fig. 5-9 The levels of calcium deposited by UMR-106 cells. UMR-106 
ceils were cultured with 10% FBS containing DMEM standard medium for 4 
days and 6 days. Mineralization was allowed to occur for 2 days. Results 
are mean ± SD (n=3). Vanishing error bars represent the SD are less than 
the heights of the symbols. Std = standard medium; Supp = supplemented 
medium. 
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Fig. 5-10 The levels of inorganic phosphate deposited by UMR-106 
cells. UMR-106 cells were cultured with 10% FBS containing DMEM 
standard medium for 4 days and 6 days. Mineralization was allowed to occur 
for 2 days. Results are mean SD (n=3). Vanishing error bars represent the 
SD are less than the heights of the symbols. Std = standard medium; Supp 
=supplemented medium. 
cultures with either medium. Fig. 5-9 and Fig. 5-10 show the changes of 
calcium and phosphate deposits respectively in the cultures with 10% 
FBS containing DMEM standard medium and 10% FBS containing 
DMEM supplemented medium. Results showed that no significant 
change in the deposits of calcium phosphate was observed in the cultures 
with standard medium. In the presence of p-glycerophosphate; however, 
* 
depositions were greatly enhanced and there was an increasing trend in 
the calcium phosphate deposition from day 6 to day 8. 
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5.4 STUDIES OF CELLULAR ALP ACTIVITIES AND RELATIVE 
RATES OF COLLAGEN SYNTHESIS 
Confluent monolayer of UMR-106 cells was subcultured and 
seeded at lxlO5 cells I well to 6-welI plates with DMEM plain medium. 
The cultures were incubated at 37°C (5%C02 / 95% air) overnight. The 
medium was changed into 10% FBS containing DMEM standard 
medium and refreshed every two days. Plates were removed at day 3, 
day 7 and day 11 for the estimations of cellular bone-specific ALP 
content and of collagen synthesis. In the study of collagen synthesis, 
cells were pulsed with 3H-proline for 4 hours. 
The study of the collagen synthesis in primary RC cells was 
similar to that in UMR-106 cells. Briefly, confluent monolayer of 
primary RC cells was subcultured and seeded at lxlO4 cells / well into 6-
well plates in 15% FBS containing aMEM standard medium. The 
cultures were incubated at 37°C (5%C02 / 95% air) overnight and 
changed into aMEM plain medium for those plates used to study cellular 
bone-specific ALP content and into DMEM plain medium for those 
plates used to study the collagen synthesis. After another overnight 
incubation, the media were changed to the corresponding standard 
medium with 15% FBS. Media were refreshed at 2-day interval. Plates 
were removed at day 6 day 12 and day 18 for the estimation of cellular 
bone-specific ALP levels and collagen synthesis. In the study of 
collagen synthesis in primary RC cells, cultures were pulsed with 3H 
proline for 3 hours. 
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Fig. 5-11 Relationship of cellular bone-specific ALP levels and the rates 
of collagenase-digestible protein (CDP) synthesis in UMR-106 cells. 
UMR-106 cells were cultured with 10% FBS containing DMEM standard 
medium. Cells were pulsed with 3H-proline for 4 hours. Results are mean ± 
SD (n=3 for ALP; n=6 for CDP). Vanishing error bars represent the SD are 
less than the heights of the symbols. CPM = Counts per minute. 
The relative rate of collagen synthesis was measured by the 
release of radioactivity from the collagenase-digestible protein (CDP) by 
the action of collagenase. The relative rates of the synthesis of CDP in 
UMR-106 cells and in primary RC cells are plotted on Fig. 5-11 and Fig. 
5-12 respectively. Experimental results showed that the relative rates of 
the synthesis of CDP were always parallel to the cellular bone-specific 
ALP activities. From Fig. 5-11, there was no significant changes in the 
rates of CDP synthesis and the cellular bone-specific ALP activities 
from day 3 to day 7. However, increases of both parameters were 
observed from day 7 to day 11. In Fig. 5-12, progressive increase in the 
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Fig, 5-12 Relationship of cellular bone-specific ALP levels and the rates 
of collagenase-digestible protein (CDP) synthesis in primary RC cells. 
Primary RC cells were cultured with 15% FBS containing FBS containing 
DMEM standard medium. Cells were pulsed with 3H-proline for 3 hours. 
Results are mean SD (n=3 for ALP; n=6 for CDP). CPM = Counts per 
minute. 
rate of CDP synthesis and the cellular bone-specific ALP activities were 
observed during the culture period. Comparing to the radioactivity 
released / well / hour in both graphs, it was not surprising to find that the 
amount of the CDP synthesized by UMR-106 cells was always higher 
than that by primary RC cells. 
t 
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Discussion 
The original sequential collagenase digestion method to isolate 
fetal rat calvarial osteoblast-like cells described by Bellows et al (1986) 
documented the rejection of the cells released in the first ten minutes. 
They reported a higher proportion of osteoclasts present in this fraction. 
The fractions they used for the studies were the subsequent 4 fractions 
(from 20 minutes to 70 minutes). In the present study, however, 
majority of the cells (>80%) in the calvaria has been released in the first 
ten minutes. The pooled fraction from 20 minutes to 70 minutes was 
unable to grow up in the medium probably due to the very low cell 
density (data not shown). Therefore, we have modified the method and 
not rejected the cells released from the first ten minutes in the present 
study. The different degree of cell release by crude collagenase might be 
due to the buffer used to prepare collagenase. The authors had not 
mentioned the buffer or its formula they used. The present formula for 
crude collagenase preparation was adopted from Puzas and Felter 
(1988). The formula contained sufficient nutrients, e.g., glucose and 
BSA, powerful buffering systems, e.g., phosphate and HEPES buffer 
and sufficient calcium which is a cofactor for collagenase. This 
balanced salt solution provided sufficient nutrients for the cells during 
collagenase digestion. Furthermore, collagenase might function at its 
optimal condition in the present balanced salt solution. Another 
possibility for the strong collagenase action might be the presence of 
higher fractions of non-specific protease, such as trypsin and other 
neutral protease in the batch we purchased. 
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Fig. 5-13 Effect of age on the percentages 
of cell types found in isolated osteoblast 
preparation. (Yagiela & Woodbury, 1977) 
The use of calvaria from fetuses was due to the presence of 
higher content of undifferentiated cells or the presence of lower content 
of well-differentiated cells. Generally, fetal rats were preferable to 
neonates. Experiments had demonstrated that the fraction of osteoblasts 
was the highest in the central portion of parietal and frontal bones of the 
fetal calvaria at 19 days (Fig. 5-13) (Yagiela and Woodbury, 1977). 
Difficulties have been confronted when the periosteum was to be 
stripped away especially in the suture region. This difficulty was much 
easier to overcome when the fetus approached to maturation. Thus, in 
the present study, rat fetuses at 20 days were chosen under the dilemma 
of osteoblasts density and the ease of periosteum separation from the 
bone. As shown in the figure, the fraction of osteoblasts present in the 
central portions of the parietal and frontal bones at 20 days was not 
much lower than that at 19 days but it was much easier to strip away the 
periosteum from the fetal rat calvaria at 20 days than at 19 days. 
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In the present study, UMR-106 cells had been shown 
incapable of being cultured by supplemented medium. Cell death was 
apparent after the cells were cultured for 8 days. The cause of the cell 
death was unknown. Therefore, UMR-106 cells were cultured with 10% 
FBS containing DMEM standard medium. In the case when 
mineralization was studied, the cells were exposed to supplemented 
medium for a short period so that the fraction of cell death could be 
minimized. 
Von Kossa technique for the staining of calcium was 
employed in the present study for the visualization of mineralized 
nodules. The original method also stained cell nucleus by neutral red, 
destained by absolute alcohol and cleared by xylene. However, these 
steps were deleted in the present study because the original method was 
employed on the preparation slide samples. Cell nuclei were 
unnecessary to be stained and xylene will dissolve the polystyrene based 
culture flasks or culture plates. 
In the study of in vitro mineralization, results showed that 
UMR-106 cells were capable of forming mineralized nodules in the 
presence of (3-glycerophosphate probably due to the action of alkaline 
phosphatase. The size and the number of nodules formed by UMR-106 
cells were always larger than those nodules formed by primary RC cells. 
It was likely due to the expression of higher level of alkaline 
phosphatase by UMR-106 cells. Only in the presence of (3-
glycerophosphate did mineralization occur in the primary RC cells, 
which agreed to the observation by Bellows et al (1986). Since nodule 
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counting was subjective and inaccurate for the assessment of 
osteogenesis, other method was employed in the present study. 
Owing to the observation of bone-specific ALP in the sera of 
human and animals, osteoblasts must be capable of synthesizing and 
secreting the bone-specific ALP into the bone fluid and the ALP enters 
the circulation. The secretory nature of bone-specific ALP was assessed 
by the quantification of bone-specific ALP released into the culture 
medium. Experimental results showed that the levels of bone-specific 
ALP released into the culture medium by UMR-106 cells gradually 
increased in the first eight days (Fig. 5-1). It was not surprising since 
proliferation of UMR-106 cells was observed in this period. Increased 
amount of bone-specific ALP released was due to the increase number of 
UMR-106 cells present. A large increase was observed at day 10 and the 
subsequent levels of bone-specific ALP secreted into the medium did not 
change significantly. It was interesting to find that the large increase in 
the amount of bone-specific ALP released into the medium occurred 
after the culture had been confluent which occurred around 7 to 8 days. 
It might be the result of differentiation of UMR-106 cells after 
confluence. The large increase in the bone-specific ALP secreted might 
also be due to the continuous increase in the UMR-106 cell population 
after confluence. Cell death was observed after 8 days in culture of 
UMR-106 cells with' supplemented medium; therefore, measurement of 
bone-specific ALP released into the medium was terminated at day 8. 
Results also showed a gradual increase in the bone-specific ALP 
released into the medium and the levels were comparable to the 
counterpart cultured with standard medium. It demonstrated that the 
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presence of p-glycerophosphate did not stimulate the production of 
bone-specific ALP. 
Fig. 5-3 was the release profile by primary RC cells. Results 
showed that the levels of bone-specific ALP released by primary RC 
cells were much less than those released by UMR-106 cells. The 
mechanism of secretion of bone-specific ALP into the medium or serum 
by the osteoblasts is still unknown but they had been demonstrated to be 
released by a bacterial phosphatidylinositol-Iinked phospholipase C (PI-
PLC) from the culture of human osteosarcoma cell line, SAOS-2 
(Nakamura et al, 1988). 
Fig. 5-4 shows the changes of cellular bone-specific ALP 
levels along the culture period. The level in the culture of UMR-106 
cells with supplemented medium at day 18 was deleted, again due to cell 
death. Results demonstrated an increasing trend of the levels of cellular 
bone-specific ALP in both cell types after confluence. The increase in 
bone-specific ALP expression was not due to the proliferation of cells as 
the levels were measured by the specific activities. Results 
demonstrated the insignificant difference between the levels of cellular 
bone-specific ALP activities expressed by the cells cultured with 
standard medium or supplemented medium but the levels were always 
significantly higher in UMR-106 cells than in primary RC cells. 
In the investigation of the cellular bone-specific ALP level and 
the deposition of calcium phosphate, Fig. 5-5 and Fig. 5-6 showed that 
primary RC cells cultured with 15% FBS containing aMEM 
supplemented medium deposit higher amount of calcium phosphate than 
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the counterpart cultured with 15% FBS containing aMEM standard 
medium at day 18. The calcium phosphate deposited at day 12 by the 
primary RC cells in supplemented medium was unexpectedly lower than 
that in standard medium. It might be due to the variation of the culture. 
since the three points were determined from three separate culture plates. 
Due to the cell death, calcium phosphate levels were not determined in 
UMR-106 cells cultured with supplemented medium. 
Alkaline phosphatase had been shown to be located in the 
outer surface of cell membrane, i.e. it is an ectoenzyme (Fedde et al, 
1988). Measurement of ALP expression could be easily attained by the 
hydrolysis of substrate by the cells of monolayer in the culture well. It 
had been proven to be an invalid measurement of bone-specific ALP 
level. Several factors contributed to the invalidity. Firstly, the ALP 
measured was not specific to the bone isoform for no previous 
differentiation of the bone isoform had been done when the ALP levels 
were assayed. Secondly, substrate depletion might occur before the 
reactions were stopped, especially in the UMR-106 cells. Thirdly, cell 
death in UMR-106 cells cultured with supplemented medium could not 
reflect the true levels of ALP expressed. Finally, when UMR-106 cells 
were cultured with standard medium for a long period, especially over 
18 days, cell death also occurred and cells would be detached from the 
monolayer, resulting in the inaccurate estimations of ALP contents. Fig. 
5-7 also demonstrated the inaccurate assessment of ALP in UMR-106 
cells. 
Since cell death occurred in UMR-106 cells cultured with 
supplemented medium, attempts had been made to shorten the exposure 
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of UMR-106 cells to supplemented medium so as to reduce the fraction 
of cell death. Results were shown in Fig. 5-8 to Fig. 5-10. It 
demonstrated that the cellular bone-specific ALP activities increased 
from day 6 to day 8 and there was no significant difference between the 
cells cultured with either medium. Calcium phosphatase deposits also 
increased from day 6 to day 8 in UMR-106 cells exposed to 
supplemented medium for 2 days and the amount of calcium phosphate 
deposited was significantly higher than the counterpart cultured with 
standard medium. It strongly suggested that calcium phosphate 
deposition was the result of the action of bone-specific ALP. 
I 
Collagen synthesis is a prerequisite for osteogenesis and the 
measurement of the serum level of the C_terminal peptide released in the 
formation of tropocollagen is always taken to estimate the rate of 
collagen synthesis in vivo (Parfitt et al, 1987). Therefore, collagen 
synthesis is always regarded as an index of osteoblastic activity. In the 
present study, collagen synthesis was measured by the synthesis of 
collagenase-digestible proteins originally described by Peterkofsky and 
Diegelmann (1971). Results demonstrated a parallelism between the 
cellular bone-specific ALP activities and the rate of collagen synthesis. 
The choice of DMEM in the estimation of collagen synthesis in primary 
RC cells was due to the presence of L-ascorbic acid in the formula of 
aMEM which could interfere the result since collagen could only be 
synthesized in the presence of L-ascorbic acid. Results also 
demonstrated a higher rate of collagen synthesis in UMR-106 cells than 
in primary RC cells. The insignificant changes in cellular bone-specific 
ALP levels and rates of collagen synthesis in UMR-106 cells (Fig. 5-11) 
at day 7 might be due to the incomplete confluence. The results 
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suggested that collagen synthesis and increase in bone-specific ALP 
expression occurred after the cultures had been confluent when 
differentiation commenced. 
In conclusion, bone-specific ALP might act as an index of 
osteogenesis as its level had been shown to parallel the rate of collagen 
synthesis and the amount of calcium phosphate deposits. Malignant 
transformation leading to the high expression of bone-specific ALP 








Since the first description of the involvement of alkaline 
phosphatase (orthophosphoric-monoester phosphohydrolase, E.C. 
3.1.3.1. alkaline optimum, ALP) in bone mineralization (Robinson, 
1923; McLean et al, 1987; Genge et al, 1988) and the increased 
activities in patients with bone and liver diseases (Kay, 1930; Roberts, 
1930; Moss, 1982), the estimation of plasma alkaline phosphatase 
activities has become one of the most frequently performed tests in 
common clinical laboratory. The human alkaline phosphatases are 
consisted of enzymes with different molecular forms originating from 
liver, bone, kidney, placenta and small intestine; therefore, ALPs 
constitute a system of isoenzymes. Moreover, serum ALPs are derived 
from two main sources, liver and bone. The lack of tissue specificity of 
the plasma ALP renders itself neither an accurate nor sensitive 
biochemical parameter for the disease activity of the originating organ 
(Brixen et al, 1989; Oni et al, 1989). This is particularly important when 
total alkaline phosphatase activity is within the normal range. Therefore, 
the quantitative determination of the tissue specific isoenzyme in serum 
is a more sensitive method so as to reflect the activities of diseases. 
Furthermore, it is also essential in serial measurements to monitor the 
progress of the disease and the response to therapy. 
Alkaline phosphatases are glycoproteins. In other words, the 
molecules is consisted of two moieties, the polypeptide chains and the 
carbohydrate sidechains. Placental, intestinal, and the tissue non-
specific ALPs have different structural genes. However, the hepatic and 
the skeletal ALPs are derived from single genetic locus. The difference 
between the two enzymes is the results of post-translational modification 
with different degree of glycosylation. Hence, they are not true 
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isoenzymes, but isoforms. This difference enables us to differentiate the 
two isoforms by a carbohydrate binding protein of plant origin, the 
wheat germ lectin from Triticum vulgaris, which binds selectively to the 
N-acetylglucosamine and its derivatives (Lis and Sharon, 1973; Crofton, 
1987). The lectin binds to the alkaline phosphatase, the skeletal isoform 
being preferentially bound, leading to the precipitation of the lectin-ALP 
complex. This method thus enables the separation of the bone-specific 
isoform with the other ALP present in the serum. Since its introduction 
by Rosalki and Foo (1984), clinicians could have an alternative method 
which is easy to perform, rapid and reliable to separate the bone-specific 
isoform from the other ALP present in serum among the other 
inaccurate, tedious or impractical methods which could not resolve the 
skeletal isoform from other isoforms completely, like electrophoretic 
separation and heat inactivation method (Shephard et al9 1986;. 
Gonchoroff et al, 1991). 
Bone-specific ALP is the product of the osteoblastic cells in 
the skeleton. Increased synthesis and secretion of bone-specific ALP 
usually refers to the increase in the osteoblastic activity. The present 
studies had demonstrated the direct relationship of the level of bone-
specific ALP in plasma and the osteoblastic activity. Fracture healing is 
a biological process in which bone is regenerated through active 
osteoblastic activities (Volpin et al, 1986; Deren et al, 1990). The 
clinical monitoring of fracture healing is usually done with physical 
examination and radiological assessment. The use of biochemical 
parameter to monitor this healing process have been reported (Oni et al, 
1989; Obrant et al, 1990). The determination of total plasma alkaline 
phosphatase activities during fracture healing had been shown to be not 
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useful (Oni et al, 1989). Diurnal variation in the plasma levels of 
osteocalcin makes it impractical for the assessment of osteoblastic 
activity after fracture (Gundberg et al, 1985). The present studies made 
an attempt to use the bone-specific ALP in plasma to monitor the 
progress of fracture healing (Fig. 4-1). Those studies in local patients 
with single long bone fracture showed the variation in the plasma bone-
specific ALP was in accordance with the progress of fracture healing. 
The significant increase in the bone-specific ALP in plasma activities in 
4th, 8th and 12th week showed that the osteoblastic activity could be 
accurately reflected by the determination of the plasma level of bone-
speciflc ALP. The plasma activities then declined to the normal levels 
after 24 weeks of healing. It is noteworthy that the increase in the 
plasma bone-specific ALP did not lead to changes in the plasma liver 
ALP activities. Since the results were derived from patients with the 
long bone fractures at different site, the heterogeneity in the data made it 
difficult to draw conclusion for its clinical application. The studies of 
the plasma level of bone-specific ALP in the progress of fracture healing 
was extended to the animal model. Those studies in rabbits had 
successfully shown the validity of this parameter. The plasma levels of 
bone-specific ALP changed according to the progress of fracture healing 
(Fig. 3-4 to Fig. 3-5). Radiological analysis demonstrated that the 
plasma levels of bone-specific ALP commence to decline after the 
fractured bones have'united (Photo 3-1 to Photo 3-7). The profile of this 
parameter had also been shown irrelevant to the age since the same 
pattern of plasma bone-specific ALP was observed in the three groups of 
rabbits with fractures at different ages, viz. the immature group, the 
premature group and the mature group (Fig. 3-2 to Fig. 3-5). The 
osteoblastic activity was also reflected by the bone-specific ALP 
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activities in the callus formed after fracture with the high levels found in 
the soft woven bone (Fig. 3-6). The use of rabbit model in the fracture 
experiment is advantageous since the fracture site could be made 
uniquely and reproducibly on the tibial shaft. This greatly reduced the 
risk of data heterogeneity observed in patients. 
The present study also investigated the relationship of plasma 
bone-specific ALP in patients with osteosarcoma. The results showed 
the very significant increase in the plasma bone-specific ALP in the bone 
forming osteosarcoma (Table 4-1). This further suggested that the 
osteoblastic activity is actually and accurately reflected by the plasma 
levels of bone-specific ALP. This study, thus, provides a differential 
diagnosis of osteosarcoma. Very high levels of plasma bone-specific 
ALP might lead to diagnosis of the presence as well as the recurrence of 
osteosarcoma. 
The above investigations in patients and in rabbits only 
demonstrated the relationship of the bone-specific alkaline phosphatase 
activities in the plasma and the osteoblastic activities indirectly. A 
complete picture could be made to demonstrate the direct relationship 
between the bone-specific ALP activity and the osteoblastic activity by 
the in vitro culture of the osteoblastic cells. The present study made use 
of two sorts of osteoblastic cells, vfe. the normal osteoblasts isolated 
from the fetal rat calvaria and the radiation induced osteogenic sarcoma 
cell line, UMR-106, of rat origin. Osteoblastic activities refers to bone 
formation, or osteogenesis; it is therefore reasonable to investigate the 
relationship of bone-specific ALP activities and the osteogenic capacity. 
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Studies of in vitro culture of fetal rat calvarial osteoblasts and 
UMR-106 osteosarcoma cell line demonstrated that bone formation 
could be reflected by the levels of bone-specific ALP present in the cells. 
The amount of calcium phosphate deposited and the relative rate of 
collagen synthesis, which are the main components of bone, were 
proportional to the level of bone-specific ALP present in the cells (Fig. 
5-4 to Fig. 5-6, Fig. 5-8 to Fig. 5-12). The studies also demonstrated that 
bone-specific ALP were involved in the bone mineralization since the 
amount of calcium phosphate deposits were significantly higher in the 
presence of artificial substrate than in the absence of the substrate (Fig. 
5-5 to Fig. 5-6, Fig. 5-9 to Fig. 5-10). Natural occurring substrates in the 
body are continuously supplied since there were accumulations of 
phosphoethanolamine, pyrophosphate and pyridixal 5-phosphate in 
hypophosphatasia, a rare inherited form of rickets / osteomalacia in 
which the activity of all forms of tissue non-specific alkaline 
phosphatase is deficient (Fedde et al, 1988). Studies also demonstrated 
that the high bone-specific ALP activities found in osteosarcoma was 
correlated to the higher deposition of calcium phosphate and higher rate 
of collagen synthesis than in the normal fetal rat calvarial osteoblasts. 
In conclusion, the selective precipitation method of bone-
specific ALP with wheat germ lectin (Rosalki and Foo, 1986) is a simple 
and reliable method for the quantitative estimations of bone-specific 
ALP activities. The plasma bone-specific ALP activity reflects the 
osteoblastic activity accurately. This biochemical test can be applied in 
clinical management of conditions in which quantitative monitoring of 
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ATJP Eytraction Buffer (pH 7.0) in dH 2 0 
Mol. Wt. Cone. g/100 mL g/500 mL 
Triton X-100 0.01 % 0.01 0.05 
Na2C0310H20 286.15 12.5 mM 0.35769 1.7884 
Tris 121.14 12.5 mM 0.15142 0.7571 
NaN3 0.01 % 0.01 0.05 
Balanced Salt SSnhitinn for Collagenase (pH 7.4) in ddH20 
Mol. Wt. Cone. glL 
1. HEPES 238.3(Anhy Wt.) 25 mM 5.96 
2. NaHC03 84.01 10 mM 0.84 
3. NaCl 58.44 100 mM 5.84 
4. K2HP04 174.18 3 mM 0.52 
5. KC1 74.55 24 mM 1.79 
6. Mannitol 182.17 12 mM 2.19 
7. CaCl2-2H20 147.02 1 mM 0.15 
8. BSA — 2 mg/mL 2.00 
9. D-Glucose ' 180.2 5 mg/mL 5.00 
10.Antibiotics Penicillin 100 U/mL 10 mL 
(Gibco) rehydrated Streptomycin 100 ^g/mL 
56 
Appendix 
Hank's Balanced Salt-Solution (HBSS) pH 7.4 in ddH20 
g/0.5 L g/L gl2± 
1. CaCl2-2H20 0.0925 0.1850 0.37 
2. KC1 0.2 0.4 0.8 
3. KH2P04 0.03 0.06 0.12 
4. MgCl2-6H20 0.05 0.10 0.20 
5. MgS04-7H20 0.05 0.10 0.20 
6. NaCl 4.0 8.0 16.0 
7. NaHC03 0.175 0.35 0.70 
8. N a ^ P C V U I ^ O 0.06 0.120 0.240 
9. D-Glucose 0.50 1.00 2.00 
10% Neutral Buffered Formalin ^NRF^ (pH 7.0) in dH20 
Mol. Wt 100 mL 500 mL 
36.5% Formaldehyde 10.96 mL 54.8 mL 
Distilled water 84.04 mL 445.2 mL 
NaH2P04-2H20 156.01 0.46 g 2.3 g 
Na2HP0412H20 358.14 1.46 g 8.20 g 
1 
Pli^phn^ Buffered Saline iEBS) (pH 7.4) in ddH20 
Cone. (mM). g/05L g/L 
NaCl 140.00 4.091 8.182 
K C 1 2.70 0.101 0.201 
KH2P04 1.50 0.102 0.204 













**POPOP = 2,2'-Phenylen-bis (5-phenyloxazol) 

























Calcium Chloride·2H 20 
Ferric Nitrate·9H20 
Magnesium Sulfate (Anhydrous) 
Potassium ·Chloride 
Sodium Chloride 











































































Magnesium Sulfate (h\nhydrous) 
Sodium Chloride . 
Sodium Phosphate Monobasic (Anhydrous) 
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Calcium Nitrate-4H 20 
Potassium Chloride 
Magnesium Sulfate (Anhydrous) 
Sodium Chloride I 
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